Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.25548733244658256,2.423714501145168,0.0,0.019398985760790133,0.016,97/243,23.86%,PHF2;ISX;MRTFA;ZNF124;ZNF669;TCEA1;ZNF251;SENP1;HIRA;LRP5;PPP1R12A;RHOQ;ZNF250;RBL1;CEBPZ;ZNF2;ZGPAT;ZNF394;LMO7;ZNF256;ZNF417;ZNF587;ZNF776;ZNF211;ZNF530;ZNF419;ELP3;AASS;ACTR3;ZNF805;ZNF845;ZNF816;ZNF432;ZNF577;ZNF772;ZNF749;ZNF548;ZNF304;SETD3;ZNF473;SP110;CREB1;ZNF234;ZNF283;ZNF780B;ZFP30;ZNF175;ARID1B;ZSCAN9;ZNF165;ZNF184;ZNF101;ZNF197;TRAK1;RFX1;ZNF791;ZNF564;ZNF563;ZNF878;ZNF383;ZNF599;ZSCAN32;ZFP62;ETV5;ZNF561;ZNF426;ZNF317;SUPT3H;CDC5L;ZNF557;TFDP2;NOD2;ARID3A;MIER2;DLG1;ZNF397;FNIP2;WWP2;AATF;WWC2;FNIP1;ZNF286A;BRIP1;ZNF275;ZNF778;BCOR;ZNF436;FOXJ3;ZNF684;MLLT10;ZNF22;HDAC8;ZNF37A;ZNF79;ZNF189;TBL1X;PPARA
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,0.5319226750261233,2.3113556600968446,0.0,0.0290984786411852,0.048,11/19,20.69%,PTK2;MRTFA;CENPA;PPP1R12A;YWHAQ;RHOQ;ARHGEF7;ACTR3;ABI2;NDC80;CENPE
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,0.2492771707703078,2.1125742825174854,0.0,0.10022809309741569,0.204,68/162,24.17%,ZNF124;ZNF669;TCEA1;TAF4;TNFRSF10A;TAF1B;YWHAQ;MSH2;GTF2E2;ZNF250;RBL1;ZNF394;ZNF256;ZNF417;ZNF587;ZNF776;ZNF211;ZNF530;ZNF419;ZNF460;ZNF432;ZNF577;ZNF772;ZNF749;ZNF548;ZNF304;ZNF473;CREB1;NUP210;ZNF234;TJP1;ZFP30;ZNF175;CDK6;ARID1B;ZNF184;ZNF101;ZNF197;ING5;ZNF791;ZNF564;ZNF563;ZNF383;ZNF599;ZSCAN32;ZNF200;ZNF561;ZNF426;ZNF317;ZNF557;TFDP2;ARID3A;PRELID3A;DROSHA;ZNF286A;BRIP1;ZNF778;ZNF436;ZNF684;PRKAA2;HDAC8;ZNF37A;ZNF79;ZNF189;TBL1X;PPARA;NOTCH3;G6PC1
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,0.2755593567699717,2.1064983161321953,0.0,0.07759594304316053,0.208,51/109,23.40%,PIK3CD;ZNF124;ZNF669;ZNF251;ZNF250;ZNF2;ZNF256;ZNF417;ZNF587;ZNF211;ZNF530;ZNF419;ZNF460;ZNF805;ZNF845;ZNF816;ZNF432;ZNF577;ZNF772;ZNF749;ZNF548;ZNF304;TRAF3;ZNF473;ZNF234;ZNF283;ZNF780B;ZFP30;ZNF175;ZNF184;ZNF101;ZNF791;ZNF564;ZNF563;ZNF878;ZNF383;ZNF599;ZSCAN32;ZNF200;ZNF561;ZNF426;ZNF317;ZNF557;ZNF286A;ZNF275;ZNF778;ZNF436;ZNF684;ZNF37A;ZNF79;ZNF189
prerank,MSigDB_Oncogenic_Signatures__RAPA EARLY UP.V1 DN,0.47175721398915493,2.1024625530140595,0.0,0.06401665301060744,0.216,15/18,42.08%,SNTB1;YTHDF3;TAF4;COG5;NUP210;ZNF175;MICU1;MYCN;IGFBP3;SF3A2;COL9A2;LRIG1;PCBP4;SNTA1;SMAD9
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,0.2546517101995094,2.098685846241693,0.0,0.05415550191553912,0.216,64/150,24.17%,ZNF124;ZNF669;TCEA1;TAF4;TNFRSF10A;YWHAQ;MSH2;ZNF250;RBL1;ZNF394;ZNF256;ZNF417;ZNF587;ZNF776;ZNF211;ZNF530;ZNF419;ZNF460;ZNF432;ZNF577;ZNF772;ZNF749;ZNF548;ZNF304;ZNF473;CREB1;ZNF234;TJP1;ZFP30;ZNF175;CDK6;ARID1B;ZNF184;ZNF101;ZNF197;ING5;ZNF791;ZNF564;ZNF563;ZNF383;ZNF599;ZSCAN32;ZNF200;ZNF561;ZNF426;ZNF317;ZNF557;TFDP2;ARID3A;PRELID3A;ZNF286A;BRIP1;ZNF778;ZNF436;ZNF684;PRKAA2;HDAC8;ZNF37A;ZNF79;ZNF189;TBL1X;PPARA;NOTCH3;G6PC1
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,0.24297943057820157,2.0343153355754247,0.0,0.0796744058032452,0.332,65/156,24.17%,ZNF124;ZNF669;TCEA1;TAF4;TNFRSF10A;YWHAQ;MSH2;GTF2E2;ZNF250;RBL1;ZNF394;ZNF256;ZNF417;ZNF587;ZNF776;ZNF211;ZNF530;ZNF419;ZNF460;ZNF432;ZNF577;ZNF772;ZNF749;ZNF548;ZNF304;ZNF473;CREB1;ZNF234;TJP1;ZFP30;ZNF175;CDK6;ARID1B;ZNF184;ZNF101;ZNF197;ING5;ZNF791;ZNF564;ZNF563;ZNF383;ZNF599;ZSCAN32;ZNF200;ZNF561;ZNF426;ZNF317;ZNF557;TFDP2;ARID3A;PRELID3A;ZNF286A;BRIP1;ZNF778;ZNF436;ZNF684;PRKAA2;HDAC8;ZNF37A;ZNF79;ZNF189;TBL1X;PPARA;NOTCH3;G6PC1
prerank,Elsevier_Pathway_Collection__Proteins Involved in non-Alcoholic Fatty Liver Disease,0.43370239445074377,2.0171824262261517,0.0,0.08183947117833337,0.368,18/19,48.80%,SLC27A2;ACACA;PPARA;SLC13A5;PNPLA3;ELOVL6;NR1I2;HGF;APOE;LGALS3;IL1RN;FOSL2;SERPINE1;PTGS2;TRPV1;FOSL1;TIMP3;RBP4
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.2146840485243531,2.0013262859839682,0.0,0.0872954359235556,0.416,89/243,23.86%,ZNF326;PHF2;ISX;CDC45;ZNF124;ZNF669;ZNF251;HIRA;PRMT2;LRP5;YWHAQ;ZNF250;ZNF2;ZGPAT;ZNF394;ZNF256;ZNF417;ZNF587;ZNF776;ZNF211;ZNF530;ZNF419;ELP3;ZNF460;ZNF805;ZNF845;ZNF816;ZNF432;ZNF577;ZNF772;ZNF749;ZNF548;ZNF304;SETD3;ZNF473;SP110;CREB1;ZNF234;ZNF283;ZNF780B;ZFP30;ZNF175;ARID1B;ZSCAN9;ZNF165;ZNF184;ZNF101;ZNF197;TRAK1;ING5;NEK4;RFX1;ZNF791;ZNF564;ZNF563;ZNF878;ZNF383;ZNF599;ZSCAN32;ZFP62;ETV5;ZNF561;ZNF426;ZNF317;VGLL4;SUPT3H;CDC5L;ZNF557;TFDP2;ARID3A;ZNF397;WWP2;AATF;WWC2;ZNF286A;BRIP1;ZNF275;ZNF778;BCOR;ZNF436;FOXJ3;ZNF684;ZNF22;ZNF37A;NIBAN2;ZNF79;ZNF189;TBL1X;PPARA
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",0.2901737990965205,1.9717555507964046,0.008620689655172414,0.0945700555838519,0.472,27/61,26.64%,PTK2;MRTFA;SENP1;CENPA;PPP1R12A;YWHAQ;RHOQ;ARHGEF7;PKP4;RALGAPA1;ACTR3;ABI2;SLC4A7;TRAK1;RAB7A;RBBP6;NDC80;WWP2;DEPDC1B;CENPE;FNBP1;ARHGAP12;MOSPD2;PLEKHG5;ARHGAP39;BAIAP2L2;CKAP4
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,0.3070065172407125,1.9222834142085752,0.0,0.12300720516501017,0.58,22/49,23.17%,CDC45;CEP164;CENPA;SLC19A1;SYCP3;PPP1R12A;YWHAQ;RBL1;GINS1;POLE4;NUP210;HAUS2;HERC2;CDK6;HAUS8;TFDP2;NDC80;NCAPG;BRIP1;CENPE;HDAC8;NEK6
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,0.27974388311916903,1.8858579812331933,0.02654867256637168,0.15519188608632106,0.684,26/60,26.64%,PTK2;MRTFA;SENP1;CENPA;PPP1R12A;YWHAQ;RHOQ;ARHGEF7;PKP4;RALGAPA1;ACTR3;ABI2;SLC4A7;RAB7A;RBBP6;NDC80;WWP2;DEPDC1B;CENPE;FNBP1;ARHGAP12;MOSPD2;PLEKHG5;ARHGAP39;BAIAP2L2;CKAP4
prerank,MSigDB_Oncogenic_Signatures__RPS14 DN.V1 DN,0.43889600227628406,1.7991907975056423,0.009615384615384616,0.23763757556967915,0.852,16/17,52.12%,FOXRED2;MSH2;CENPE;LRRC20;CBS;PKLR;MKI67;ERCC6L;CLCN4;DEPDC1;KIF23;PYCR1;PBK;SLC43A1;CNN3;DNAJA4
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,0.38358645369643013,1.7514122240151968,0.03305785123966942,0.29167760733188025,0.928,12/22,26.02%,SLC35D2;PHKA2;ST3GAL1;CHST11;RPIA;MAP4K5;NUP210;PAPSS1;MANBA;HS2ST1;G6PC1;PKLR
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,0.41551339285714284,1.7337733506001798,0.024390243902439025,0.30165422858028657,0.944,9/15,23.17%,CEP164;CENPA;HAUS2;HAUS8;NDC80;NCAPG;CENPE;HDAC8;NEK6
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3104026048103433,-1.727481730980639,0.008064516129032258,1.0,0.948,18/39,23.47%,NR2C2;USP37;APP;ZNF33A;ZNF341;ZNF90;ZNF66;ZNF708;ZNF85;ZNF117;ZNF221;ERC1;ZBTB38;NR3C1;CREBBP;RB1;RABL3;ZNF678
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",0.30488947171225184,1.7136687933723507,0.016666666666666666,0.3149304094603273,0.964,18/39,23.17%,CDC45;CEP164;CENPA;SLC19A1;PPP1R12A;RBL1;GINS1;POLE4;NUP210;HAUS2;CDK6;HAUS8;TFDP2;NDC80;NCAPG;CENPE;HDAC8;NEK6
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,0.3581874668485262,1.712180623489391,0.02586206896551724,0.2984020456733306,0.964,12/23,22.55%,TCEA1;TAF4;TNFRSF10A;YWHAQ;MSH2;RBL1;ING5;TFDP2;ARID3A;PRELID3A;BRIP1;PRKAA2
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.38408227140621504,1.6724777476348025,0.017699115044247787,0.34837345262085617,0.968,11/17,33.44%,LPAR1;TRAF3;NOD2;NEK6;PLEKHG5;CD4;APOL3;TSPAN6;CX3CL1;EDA2R;UNC5CL
prerank,MSigDB_Hallmark_2020__Coagulation,-0.36990595611285265,-1.6534765978053567,0.023076923076923078,1.0,0.988,19/19,63.63%,CPQ;PROS1;CTSO;RAPGEF3;SH2B2;HRG;CD9;ITIH1;C1R;PRSS23;MMP2;LAMP2;TIMP3;A2M;ANXA1;ITGA2;SERPINE1;CTSH;FN1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.3073241191797893,-1.629441060667066,0.03305785123966942,1.0,0.996,15/34,23.47%,NR2C2;ZNF33A;ZNF341;ZNF90;ZNF66;ZNF708;ZNF85;ZNF117;ZNF221;ERC1;ZBTB38;NR3C1;CREBBP;RB1;ZNF678
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.2907437856659251,1.5957383474837286,0.05714285714285714,0.489313890834667,0.988,12/29,20.39%,SMC5;MSH2;FANCL;BRSK1;TDP1;HERC2;NEK4;RBBP6;ATR;FNIP2;AATF;TLK2
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.2790008353318422,1.5956853535322524,0.038461538461538464,0.4648481962929336,0.988,16/37,25.17%,TAF4;RHOQ;PPP1R16B;ARHGEF7;TRAF3;ING5;ATR;DLG1;DEPDC1B;WWC2;NEK8;BRIP1;PRKAA2;ARHGAP12;PLEKHG5;ARHGAP39
prerank,WikiPathway_2021_Human__Ciliary landscape WP4352,-0.39337384259259267,-1.5929658989970876,0.05084745762711865,1.0,0.996,8/15,20.39%,ANKS6;EXOC6B;NEK7;EXOC2;CREBBP;RNGTT;TBC1D4;RB1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.21172506263011176,1.571970795916142,0.019801980198019802,0.4928266144467398,0.988,35/89,27.57%,MRTFA;TCEA1;SENP1;PRMT2;LRP5;PPP1R12A;RHOQ;RBL1;CEBPZ;LMO7;ACTR3;ZNF304;SETD3;CREB1;ZNF175;ARID1B;ING5;NEK4;ETV5;SUPT3H;CDC5L;TFDP2;NOD2;AATF;FOXJ3;MLLT10;HDAC8;NIBAN2;TBL1X;PPARA;CD4;PROX1;PADI2;MYCN;SALL1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.3529086797882727,1.564676134607232,0.03225806451612903,0.48761996025986104,0.988,14/19,39.00%,DLG3;LIN7A;ARL5A;RAB40C;RAPGEF6;DLG1;THY1;LRRC4;ITGA4;CRB3;ITGAL;CDH1;SYNE3;CPE
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.22085950706044744,1.5578064096545923,0.010752688172043012,0.48307691715184997,0.988,29/69,28.88%,MRTFA;TCEA1;SENP1;LRP5;PPP1R12A;RHOQ;RBL1;CEBPZ;LMO7;ACTR3;ZNF304;SETD3;CREB1;ZNF175;ETV5;CDC5L;TFDP2;NOD2;AATF;FOXJ3;MLLT10;HDAC8;TBL1X;PPARA;NOTCH3;PROX1;MYCN;SALL1;CX3CL1
prerank,Reactome_2022__DNA Repair R-HSA-73894,0.3646827199757685,1.537218815664083,0.05,0.5187207963327944,0.996,9/17,22.01%,TCEA1;SLC19A1;MSH2;FANCL;POLE4;TDP1;HERC2;BRIP1;DCLRE1C
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.36619718309859156,-1.531341379459497,0.06956521739130435,1.0,1.0,17/17,63.94%,A1BG;APP;NHLRC2;PROS1;SYT2;HRG;CD9;SYT7;LAMP2;QSOX1;FLNA;TIMP3;A2M;SERPINE1;STX1A;FN1;HGF
prerank,WikiPathway_2021_Human__MAPK Signaling Pathway WP382,-0.3741656286927917,-1.5184954089607123,0.051094890510948905,1.0,1.0,12/17,42.63%,AKT3;RAP1B;RASA2;MAP2K6;PAK2;RAP1A;MAP2K5;RASGRP2;DUSP4;NTF3;MAP4K1;RASGRP3
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.24999136690647483,1.4986453228969288,0.04411764705882353,0.6060243151670838,0.996,19/45,26.64%,ERP44;CAB39;PLAUR;LILRA2;CD33;IGF2R;SLC27A2;RAB7A;PLD1;CPPED1;CD300A;MANBA;ATAD3B;CD53;SYK;MOSPD2;NFAM1;PADI2;CKAP4
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,0.36259726721024604,1.4933458785489984,0.072,0.5974514556904884,0.996,10/16,26.10%,PHF2;ASH1L;ELP3;SETD3;ARID1B;ING5;SUPT3H;HDAC8;TBL1X;PADI2
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.3058176100628931,1.4646385909363435,0.09230769230769231,0.642681213445436,1.0,23/23,69.96%,SNTB1;PLAUR;PLOD2;CDH2;THY1;COL12A1;IGFBP3;MSX1;ITGB5;DPYSL3;FN1;SERPINE1;ITGA2;TIMP3;FLNA;QSOX1;MMP2;SLIT3;CD44;COL7A1;PCOLCE;BASP1;PMP22
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,-0.2740801783896457,-1.4642757028029476,0.05755395683453238,1.0,1.0,13/32,26.10%,CYP2C8;GGT5;NCOA1;AHRR;CYP4V2;SULT1B1;TPST1;AADAC;GSTA1;GSTA2;CYP39A1;GLYAT;ACSM2B
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.2702245273013867,1.462636404372732,0.09917355371900827,0.6256172907854818,1.0,14/32,23.94%,CDC14B;CEP164;YTHDF3;CENPA;UBXN2A;NUDCD3;ACTR3;HAUS2;RAB7A;HAUS8;EIF2A;CENPE;NEK6;SEPTIN6
prerank,WikiPathway_2021_Human__TGF-beta Signaling Pathway WP366,-0.3338292333032251,-1.4387903760839178,0.16312056737588654,1.0,1.0,13/19,40.00%,APP;TGIF1;CREBBP;MAP2K6;PAK2;WWP1;ZFYVE16;ZEB1;TGFB1I1;PML;MAPK4;FOSB;MAP4K1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3254816253844909,1.4371148533323392,0.10833333333333334,0.6747836857309327,1.0,7/17,16.06%,MELK;CEP164;PPP1R12A;BRSK1;HAUS2;CDK6;HAUS8
prerank,KEGG_2021_Human__Viral carcinogenesis,0.3163585434173669,1.436479050912189,0.07194244604316546,0.654715769426667,1.0,10/20,24.48%,PIK3CD;YWHAQ;GTF2E2;RBL1;TRAF3;CREB1;CDK6;DLG1;HDAC8;SYK
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.2934651503403119,-1.434443691261586,0.109375,1.0,1.0,9/23,20.39%,AKT3;CYP2C8;KPNA3;CREB3L2;GSTA1;GSTA2;CYP3A7;PIK3CB;RB1
prerank,MSigDB_Oncogenic_Signatures__VEGF A UP.V1 DN,0.29128814348940135,1.4279842210912224,0.104,0.659878402733974,1.0,8/23,10.81%,CDC45;ZNF124;CENPA;HIRA;CEBPZ;PRPF40A;AASS;SLC4A7
prerank,MSigDB_Oncogenic_Signatures__ESC V6.5 UP EARLY.V1 DN,-0.30067411580016623,-1.4220281420109417,0.11363636363636363,1.0,1.0,20/21,64.63%,APP;GJB5;TGFB1I1;BMP4;INHBB;PMP22;OAF;PCOLCE;KLF4;AQP3;CD44;PBX1;ALX3;CDC42EP1;ANXA1;MOGAT2;SERPINE1;CPE;FHL2;MAPK13
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.2741860895301517,1.4096161058597834,0.088,0.6913919768806609,1.0,15/23,39.23%,PHKA2;ST3GAL1;PLOD2;CDH2;WWP2;MANBA;CKAP4;IGF2BP3;IGFBP3;MELTF;FN1;APOE;CTSH;CPE;FDXR
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.3504261363636364,-1.404890835516646,0.13076923076923078,1.0,1.0,9/15,29.03%,CYP2C8;GGT5;BTD;AASDH;CYP3A7;VNN1;GLYAT;SGPL1;ECHDC3
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.28270993259191535,1.3987924917402963,0.09322033898305085,0.7017436136952491,1.0,9/24,20.69%,ARHGEF7;CLIP2;RAB3GAP1;CD2AP;RAPGEF6;DLG1;NDC80;TBCD;CENPE
prerank,TRRUST_Transcription_Factors_2019__STAT3 human,-0.3179579041648008,-1.3950713493095315,0.1044776119402985,1.0,1.0,9/19,29.27%,POU2F1;STS;NR2C2;PROS1;TNFRSF10B;FGL1;OAS1;SHH;CCND2
prerank,MSigDB_Oncogenic_Signatures__STK33 DN,-0.2906967042136004,-1.388014627599056,0.09701492537313433,1.0,1.0,11/26,23.17%,RRP15;TRIM58;NEO1;NHLRC2;MREG;ARHGEF26;TNKS;PIK3CB;VPS13C;KCNN2;GAS2
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.29292895739215175,1.3866782076272262,0.11016949152542373,0.7146244019232247,1.0,17/23,44.48%,PIK3CD;LPAR1;PTK2;PPP1R12A;ARHGEF7;ACTR3;ABI2;ITGA3;ITGA4;ITGAL;ITGB5;FGF1;FN1;BCAR1;SPATA13;IQGAP3;ITGA2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.19955787053052254,-1.3731181285746124,0.08823529411764706,1.0,1.0,32/76,29.88%,TRIM58;NR2C2;SLC2A10;APP;ZNF33A;ZNF341;MYOM1;ZNF90;ZNF66;ZNF708;ZNF85;ZNF117;ZNF221;ERC1;ZNF451;KDM6A;ZBTB38;NR3C1;DTNBP1;CREBBP;ZNF148;PIK3CB;RB1;ADAM10;ZNF678;TRIM44;SHH;HIC1;ZNF507;ITGAX;SUFU;BMP4
prerank,MSigDB_Oncogenic_Signatures__TGFB UP.V1 UP,0.3060425423105812,1.3709740326404567,0.12403100775193798,0.7409026918781775,1.0,17/18,63.71%,PIK3CD;CHST11;SMOX;TMC7;BCOR;ARHGAP12;FGF1;PPP1R13L;DLC1;TBX3;BHMT;MATN1;HLX;KLF4;CD163;NTF3;LIPG
prerank,MSigDB_Oncogenic_Signatures__KRAS.600 UP.V1 UP,-0.2866352201257862,-1.368835369447559,0.13846153846153847,1.0,1.0,21/23,60.31%,ZNF528;EXOC6B;TFPI;DCBLD2;ZEB1;KCNAB3;FAM174B;PELI2;DUSP4;MAP4K1;DNAJA4;KCNC1;RBP4;GFI1;A2M;ITGA2;PTGS2;TBX3;CYP27B1;STX1A;FMNL2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Myocarditis,0.3265625,1.3662435259740588,0.12612612612612611,0.73608373747887,1.0,15/15,67.72%,PPARA;CD4;CD86;HGF;IL1RN;SERPINE1;SMAD9;PTGS2;MMP2;CD2;RORC;CD274;BDKRB2;CIITA;IL21R
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.31862824456316435,1.3626315297405984,0.14728682170542637,0.7269376691171763,1.0,9/17,28.80%,PLAUR;CD2AP;VGLL4;WWC2;FNIP1;PRKAA2;ARHGAP12;PPARA;TSPAN6
prerank,KEGG_2021_Human__Hepatocellular carcinoma,-0.3384615384615385,-1.361781833644028,0.1111111111111111,1.0,1.0,7/15,20.39%,AKT3;POLK;ARID2;GSTA1;GSTA2;PIK3CB;RB1
prerank,KEGG_2021_Human__MAPK signaling pathway,-0.3101820728291316,-1.3590347658295252,0.13432835820895522,1.0,1.0,13/20,42.63%,AKT3;RAP1B;RASA2;MAP2K6;PAK2;RAP1A;MAP2K5;RASGRP2;DUSP4;NTF3;MAP4K1;TEK;RASGRP3
prerank,KEGG_2021_Human__Hepatitis B,-0.31836214635276405,-1.3566394179893786,0.14634146341463414,1.0,1.0,7/16,20.39%,AKT3;CREB3L2;CREBBP;PTK2B;MAP2K6;PIK3CB;RB1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.2909803921568627,1.3539059068537291,0.14285714285714285,0.7355023351278522,1.0,20/20,71.35%,PIK3CD;PPP1R16B;ZNF304;GTF2I;NIBAN2;FGF1;CTSH;HK2;SERPINE1;PTPRM;THBS4;PIK3R6;CYP1B1;TEK;KLF4;HRG;PML;ADGRA2;RAPGEF3;ITGAX
prerank,MSigDB_Oncogenic_Signatures__PRC2 SUZ12 UP.V1 DN,-0.32239468557376005,-1.3538062849588715,0.13274336283185842,1.0,1.0,12/17,43.71%,TRIM58;GGT5;POU2F1;DCBLD2;PLEKHA5;ZNF177;VILL;IPCEF1;STAT5A;GIMAP4;CYP1B1;SLC15A3
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.2776271347699919,-1.3523255067850124,0.128,1.0,1.0,8/21,21.08%,PARD3;TLE4;KPNA3;DNAJB14;CREBBP;PTK2B;SLC7A9;ADAM10
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.22286765417755838,1.3487088599363093,0.11278195488721804,0.7118215337599929,1.0,17/43,26.64%,ERP44;CAB39;PLAUR;CD33;IGF2R;SLC27A2;RAB7A;PLD1;CPPED1;CD300A;MANBA;ATAD3B;CD53;MOSPD2;NFAM1;PADI2;CKAP4
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.22286765417755838,1.3487088599363093,0.11278195488721804,0.7118215337599929,1.0,17/43,26.64%,ERP44;CAB39;PLAUR;CD33;IGF2R;SLC27A2;RAB7A;PLD1;CPPED1;CD300A;MANBA;ATAD3B;CD53;MOSPD2;NFAM1;PADI2;CKAP4
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.2887736789631107,1.3480637654105088,0.13675213675213677,0.6964709034117823,1.0,12/20,35.91%,PPP1R9A;ABI2;CD2AP;DLG1;SVIL;ARHGAP12;BAIAP2L2;PROX1;SHROOM1;CARMIL2;DPYSL3;SPIRE2
prerank,Reactome_2022__M Phase R-HSA-68886,0.29167219269340244,1.339368210018115,0.09917355371900827,0.7047143458220368,1.0,10/22,23.17%,CEP164;CENPA;NUP210;HAUS2;HAUS8;NDC80;NCAPG;CENPE;HDAC8;NEK6
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.33229085222830335,-1.3351764491723455,0.14482758620689656,1.0,1.0,16/16,67.26%,CYP2C8;STS;CYP4V2;CYP3A7;CYP39A1;SHH;ARV1;CYP1A2;VDR;CYP1B1;HSD17B3;PRLR;CYP27B1;FDXR;SULT1A1;NR1I2
prerank,MSigDB_Oncogenic_Signatures__AKT UP.V1 DN,-0.3143271229428478,-1.3336214093123004,0.15702479338842976,1.0,1.0,14/16,56.83%,TYW1;CDC42BPA;ZEB1;HIC1;SLCO3A1;STAT5A;C1R;GNA14;FBXO32;RORC;SLIT3;TIMP3;IL13RA1;TNNC2
prerank,WikiPathway_2021_Human__Ras signaling WP4223,-0.298050250189135,-1.3334218797371513,0.15447154471544716,0.9820460285857313,1.0,8/18,24.79%,AKT3;RAP1B;RASA2;EXOC2;PAK2;PIK3CB;GRIN2B;RAP1A
prerank,KEGG_2021_Human__Ras signaling pathway,-0.2774343386044607,-1.3280744439275642,0.12121212121212122,0.9612915801289161,1.0,9/22,24.79%,AKT3;PLAAT3;RAP1B;RASA2;EXOC2;PAK2;PIK3CB;GRIN2B;RAP1A
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.18471705266060104,1.3248314911168297,0.11023622047244094,0.725544624413738,1.0,35/86,28.57%,PIK3CD;CDC14B;PHKA2;MELK;ST3GAL1;PPP1R12A;PPM1H;ASB3;COQ8A;DAD1;LMTK2;LMO7;MAP4K5;BRSK1;SETD3;CREB1;CDK6;NEK4;PLOD2;CDH2;FNIP2;WWP2;ERN1;TLK2;MANBA;PRKAA2;NEK6;FAM20B;SYK;MAP3K9;FBXO31;CKAP4;PSMB9;PTPRH;IGFBP3
prerank,MSigDB_Oncogenic_Signatures__TBK1.DF DN,0.2669996494917631,1.3246333149465672,0.15079365079365079,0.7092754168788893,1.0,10/27,18.15%,MTAP;SMC5;MSH2;PKP4;CDK6;CD2AP;CLEC16A;ZNF557;ANKRD11;ACAP2
prerank,MSigDB_Oncogenic_Signatures__ESC V6.5 UP LATE.V1 UP,0.2826093514328809,1.3149559194098293,0.16535433070866143,0.720564548870238,1.0,17/20,54.90%,PLOD2;CDH2;RNF130;MICU1;PKDCC;CTSH;SH3RF1;SGCE;CYBA;ZFPM1;SOAT2;MOGAT2;RBP4;S100G;ZDHHC9;SLIT3;TMPRSS2
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,0.3069114533484149,1.3070692992412534,0.16521739130434782,0.7285162587340208,1.0,14/18,43.86%,LIN7A;ARHGEF7;CREB1;DLG1;PRKAA2;KCNJ10;MAOA;GPRIN1;GNB5;GNG2;STX1A;SLC6A4;SLC38A1;PPFIA4
prerank,MSigDB_Oncogenic_Signatures__HOXA9 DN.V1 DN,0.3090287758295806,1.2965347060753247,0.19658119658119658,0.7444876716175576,1.0,13/17,43.01%,CDC45;GINS1;FANCL;CD300A;CBS;ITGA4;ELOVL6;ITGB5;SPON2;COL9A3;RNF144A;ZNF395;SLC38A1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.2980806247593907,-1.2847208665452772,0.17266187050359713,1.0,1.0,8/19,26.64%,SGPP1;TYW1;ABHD3;GSTA1;GSTA2;HACD2;PLPP1;SGPL1
prerank,MSigDB_Oncogenic_Signatures__TBK1.DF UP,-0.2708570096453653,-1.2823683006787123,0.15079365079365079,1.0,1.0,15/24,36.45%,SLC2A10;TPST1;PROS1;MREG;DERA;RNGTT;TNFRSF10B;RB1;ZFYVE16;SLCO3A1;FEZ1;TNFAIP2;CD83;EML1;LIPG
prerank,Elsevier_Pathway_Collection__Proteins Involved in Pulmonary Hypertension,-0.29751904321207373,-1.270053572994447,0.18382352941176472,1.0,1.0,17/18,63.94%,TFPI;PDE5A;SOD2;BMP4;HLA-B;TNFSF14;TEK;MMP2;KCNC1;PTGS2;NFATC2;SLC6A4;SMAD9;SERPINE1;IL1RN;APOE;HGF
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.2686294647951615,-1.2584143437173785,0.1694915254237288,1.0,1.0,23/25,63.63%,A1BG;APP;NHLRC2;RAP1B;PROS1;PIK3CB;RAP1A;RAPGEF3;RASGRP2;HRG;VAV1;CD9;GNA14;PIK3R6;LAMP2;QSOX1;FLNA;TIMP3;BCAR1;SERPINE1;GNG2;GNB5;FN1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.29170358787246975,-1.2574751108989863,0.18571428571428572,1.0,1.0,10/16,40.08%,DCBLD2;SGK3;RB1;ADAM10;PTPRJ;RASGRP2;PML;HRG;IL17RB;LTBP4
prerank,WikiPathway_2021_Human__Regulation of Actin Cytoskeleton WP51,0.2952306489444879,1.2499401870861144,0.20689655172413793,0.8789155059016321,1.0,5/16,10.73%,PIK3CD;PTK2;PPP1R12A;ARHGEF7;ABI2
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,0.19031975094170872,1.245995650325245,0.19130434782608696,0.8714697429783527,1.0,17/58,17.68%,PTK2;ST3GAL1;TCEA1;TAF4;YWHAQ;GTF2E2;DAD1;ACTR3;TRAF3;CREB1;ABI2;NUP210;TJP1;IRAK2;RAB7A;MEFV;NOD2
prerank,MSigDB_Oncogenic_Signatures__LEF1 UP.V1 UP,0.27524412633371464,1.2451190151711196,0.128,0.8564652213388845,1.0,18/21,57.68%,CHST11;WWC2;ZNF22;PRKAA2;FNBP1;CBS;KRT23;DENND1C;MAOA;FN1;SERPINE1;COL9A3;FOSL1;MAOB;ARHGAP4;EPB41L4A;FNDC4;ZAP70
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,0.26475050845268966,1.2450088711569396,0.211864406779661,0.8401472509636315,1.0,8/22,17.68%,ST3GAL1;YWHAQ;DAD1;TRAF3;NUP210;TJP1;IRAK2;NOD2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.24784837941768914,-1.243804029668094,0.234375,1.0,1.0,11/25,26.80%,TTC3;FBXO27;KLHL3;UBE3D;TNKS;WWP1;NEDD4;SHPRH;RNF217;AMFR;HECTD2
prerank,WikiPathway_2021_Human__Integrin-mediated Cell Adhesion WP185,-0.2895105074649858,-1.2427104214841913,0.2127659574468085,1.0,1.0,9/18,28.80%,AKT3;MAPK6;RAP1B;MAP2K6;PAK2;ITGA1;RAP1A;MAP2K5;ITGAX
prerank,WikiPathway_2021_Human__Nuclear Receptors Meta-Pathway WP2882,-0.27651398533620686,-1.2420122025350802,0.18055555555555555,1.0,1.0,8/24,19.07%,NCOA1;SLC2A10;AHRR;POLK;NR3C1;GSTA1;GSTA2;CYP3A7
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.20453348391168397,-1.2364073930788568,0.1968503937007874,0.9948618115093222,1.0,21/48,28.73%,AKT3;SIK3;PEAK1;APP;MAPK6;BIRC6;VRK2;AGK;SGK3;WNK3;NEK7;CDK19;PTK2B;TEC;PAK2;PIK3CB;ADAM10;CDC42BPA;TESK2;HCK;LIPE
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.306849100860047,1.2346177722354512,0.18032786885245902,0.8550476031486728,1.0,12/16,43.71%,CDC45;CENPA;HIRA;RBL1;NDC80;CENPE;MKI67;KIF23;SLC7A1;SLC38A1;UBE2C;PBK
prerank,WikiPathway_2021_Human__Metapathway biotransformation Phase I and II WP702,-0.2588739553717584,-1.2337978426230816,0.22297297297297297,0.9743310547859577,1.0,9/23,23.78%,CYP2C8;CYP20A1;CYP4V2;SULT1B1;GSTA1;GSTA2;CYP3A7;CYP39A1;GLYAT
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.2535766145349806,1.2326969370103356,0.1875,0.8457774782404868,1.0,14/22,37.22%,PIK3CD;PTK2;ARHGEF7;ELP3;ZNF304;TJP1;F7;SH3RF2;FGF1;CARMIL2;SEMA3G;HGF;FN1;CTSH
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,-0.29036821921888384,-1.2319022417382925,0.20930232558139536,0.9530377270985825,1.0,14/16,52.43%,KPNA3;OAS1;NEDD4;HLA-B;CIITA;PML;OASL;HERC5;CD44;TRIM46;IFI6;GBP4;MID1;FLNA
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,0.2906208355658134,1.230210316244322,0.22522522522522523,0.8372099317689149,1.0,10/18,32.66%,EPHX2;SLC27A2;CYP4F3;ACSF3;ACACA;PRKAA2;PTGR1;ELOVL2;ELOVL6;ACSL5
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.16152242344957282,1.2166874929515055,0.21052631578947367,0.8651065877232363,1.0,30/92,23.86%,ZNF124;ZNF669;PRMT2;YWHAQ;ZGPAT;ZNF256;AASS;ZNF749;CREB1;ZNF175;ZNF599;ETV5;VGLL4;ZNF557;TFDP2;MIER2;DLG1;FNIP2;WWP2;WWC2;FNIP1;ZNF778;BCOR;ZNF436;ZNF684;HDAC8;NIBAN2;ZNF79;TBL1X;PPARA
prerank,MSigDB_Oncogenic_Signatures__ATF2 S UP.V1 UP,0.264682850430697,1.215798480446258,0.19491525423728814,0.8520831290197058,1.0,18/18,73.90%,PPM1H;ANKRD11;PSMB9;RSPH6A;KIF23;SLC13A3;DBNDD1;MYO7A;ABLIM3;HSD17B3;PIR;ALX3;PLCB4;GNA14;IL17RB;EFNB2;PML;APOL6
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.24142778768344533,-1.2102347153993027,0.203125,1.0,1.0,13/27,30.66%,TBC1D12;EVI5;RIC1;RABGAP1;CCL23;BCAS3;ARHGEF26;TBC1D4;SIPA1L1;RAP1A;SNX13;RAPGEF3;RASGRP2
prerank,Reactome_2022__SUMOylation R-HSA-2990846,0.29399363341896567,1.2075013145249052,0.22950819672131148,0.861978617291951,1.0,8/16,26.25%,SMC5;MRTFA;SENP1;NUP210;HERC2;RWDD3;PPARA;CBX2
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,0.26701229804678084,1.2064219331111083,0.22330097087378642,0.8496254065318473,1.0,10/19,29.03%,PRPF40A;ZNF473;NUP210;CDC5L;PARN;UPF2;IGF2BP1;PSMB9;IGF2BP3;SF3A2
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,0.21042289348171697,1.2003495660433534,0.216,0.8551993553189007,1.0,15/37,25.79%,AGPAT3;YWHAQ;RHOQ;COG5;RAB3GAP1;ACTR3;TJP1;IGF2R;RAB7A;CENPE;PRKAA2;FNBP1;SORT1;CD4;SPTBN2
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,0.19005210029306419,1.1934128208607486,0.28440366972477066,0.8621232588524482,1.0,18/50,26.64%,SENP1;RHOQ;ARHGEF7;PKP4;RALGAPA1;ABI2;SLC4A7;RAB7A;RBBP6;WWP2;DEPDC1B;FNBP1;ARHGAP12;MOSPD2;PLEKHG5;ARHGAP39;BAIAP2L2;CKAP4
prerank,KEGG_2021_Human__Salmonella infection,-0.2740276690159228,-1.1863471201320366,0.26573426573426573,1.0,1.0,7/18,19.61%,AKT3;KPNA3;ARHGEF26;EXOC2;TNFRSF10B;MAP2K6;PIK3CB
prerank,WikiPathway_2021_Human__Ciliopathies WP4803,-0.28791301074334696,-1.1859380807275088,0.3106060606060606,1.0,1.0,8/16,28.96%,ANKS6;TTBK2;WDPCP;ATXN10;CPLANE1;SDCCAG8;CEP120;SUFU
prerank,WikiPathway_2021_Human__Chemokine signaling pathway WP3929,-0.2791839131893948,-1.182988159735619,0.25833333333333336,1.0,1.0,9/18,31.35%,AKT3;PARD3;RAP1B;PTK2B;PIK3CB;RAP1A;HCK;RASGRP2;ADCY3
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.25031540860291845,-1.1760667662351076,0.23255813953488372,1.0,1.0,10/22,31.35%,AKT3;PARD3;CCL23;RAP1B;PTK2B;PIK3CB;RAP1A;HCK;RASGRP2;ADCY3
prerank,KEGG_2021_Human__Tight junction,0.28707932692307697,1.1662791567890207,0.24390243902439024,0.9327413973179911,1.0,8/15,29.27%,DLG3;ACTR3;TJP1;RAPGEF6;DLG1;PRKAA2;CRB3;ARHGEF18
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.2558869701726846,-1.1650971797550993,0.2765957446808511,1.0,1.0,9/21,24.79%,AKT3;CYP2C8;POU2F1;RAP1B;SOD2;TNFRSF10B;MAP2K6;PIK3CB;RAP1A
prerank,WikiPathway_2021_Human__Hepatitis B infection WP4666,-0.28703124999999996,-1.1636164029778655,0.3,1.0,1.0,6/15,19.61%,AKT3;CREB3L2;CREBBP;PTK2B;MAP2K6;PIK3CB
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.20921211934267436,1.1627687469140457,0.2184873949579832,0.9283353347139407,1.0,20/36,37.84%,PIK3CD;LPAR1;PTK2;YWHAQ;CREB1;CDK6;ITGA3;PRKAA2;G6PC1;SYK;ERBB3;ITGA4;COL9A2;ITGB5;FGF1;COL4A5;HGF;FN1;GNB5;GNG2
prerank,WikiPathway_2021_Human__Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.22539432176656143,1.1622618738619042,0.25210084033613445,0.9157552960728548,1.0,15/27,37.84%,PIK3CD;LPAR1;PTK2;CAB39;CREB1;ACACA;ITGA3;PRKAA2;ITGA4;ITGAL;ITGB5;FGF1;HGF;FN1;GNG2
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.27414593671714194,1.1553869487592294,0.288,0.9241040287220145,1.0,4/16,5.48%,PIK3CD;GPAT4;AGPAT3;LCLAT1
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,0.19176590182979963,1.151883041611646,0.256198347107438,0.9217502695723127,1.0,16/43,26.64%,ERP44;CAB39;PLAUR;CD33;IGF2R;SLC27A2;RAB7A;CPPED1;CD300A;MANBA;ATAD3B;CD53;MOSPD2;NFAM1;PADI2;CKAP4
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,0.21132698916204065,1.147953435925431,0.288135593220339,0.9213783426308616,1.0,15/34,27.64%,HIRA;CREB1;NUP210;CDK6;TNFRSF21;PARN;TFDP2;FNIP2;FNIP1;ERN1;BRIP1;TBL1X;PPARA;CBX2;PSMB9
prerank,Elsevier_Pathway_Collection__Proteins Involved in Neuroblastoma,0.22998430141287263,1.1473394980158615,0.3269230769230769,0.9097979553260119,1.0,20/21,70.27%,PTK2;TNFRSF10A;CDH2;HDAC8;PROX1;MYCN;CX3CL1;MSX1;LIN28B;HGF;SERPINE1;TNFRSF10D;TIMP3;MYCL;CD44;NTF3;VAV1;EFNB2;CIITA;BMP4
prerank,MSigDB_Oncogenic_Signatures__STK33 NOMO DN,-0.24774297847148702,-1.1451330021530448,0.29508196721311475,1.0,1.0,8/22,21.93%,RRP15;TRIM58;NEO1;NHLRC2;BIVM;TNKS;NEDD4;VPS13C
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.19637154072344076,1.143857083461745,0.2831858407079646,0.9061893863110273,1.0,14/37,27.57%,PRMT2;LRP5;SETD3;CREB1;ARID1B;ING5;NEK4;SUPT3H;NIBAN2;TBL1X;PPARA;CD4;MYCN;SALL1
prerank,KEGG_2021_Human__cAMP signaling pathway,-0.2596696407041234,-1.143270437022471,0.2421875,1.0,1.0,10/19,31.35%,AKT3;RAP1B;CREB3L2;CREBBP;PIK3CB;GRIN2B;RAP1A;LIPE;RAPGEF3;ADCY3
prerank,MSigDB_Oncogenic_Signatures__HOXA9 DN.V1 UP,0.22571382350562158,1.1430123992831671,0.2916666666666667,0.8960785125518602,1.0,8/27,18.69%,SLC35D2;USP15;ZNF394;FNDC3A;PHTF2;FNDC3B;NOD2;RNF130
prerank,WikiPathway_2021_Human__Hippo-Merlin Signaling Dysregulation WP4541,0.25768025078369905,1.13618010341047,0.3274336283185841,0.9044084290048372,1.0,11/19,36.37%,PTK2;PPP1R12A;VGLL4;CDH2;ITGA3;ITGA4;ITGAL;ITGB5;CDH1;LIN28B;CDH15
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.26627556640962,-1.135825422625046,0.31451612903225806,1.0,1.0,7/18,21.16%,AKT3;POLK;MAP2K6;OAS1;PIK3CB;RB1;NEDD4
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.2568724717276405,1.135133992583172,0.2782608695652174,0.8946757587846098,1.0,8/17,29.27%,RHOQ;ARHGEF7;CD2AP;DEPDC1B;ARHGAP12;PLEKHG5;ARHGAP39;ARHGEF18
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.2703979996977565,-1.1343189935951834,0.29927007299270075,1.0,1.0,7/18,22.39%,ABCD3;SULT1B1;SLCO1A2;SLC23A2;ABCA6;NEDD4;CYP39A1
prerank,Reactome_2022__Neuronal System R-HSA-112316,0.21248025276461302,1.130189629308961,0.312,0.8972704490259908,1.0,29/29,79.23%,LIN7A;ARHGEF7;CREB1;DLG1;PRKAA2;KCNJ10;MAOA;HOMER3;GPRIN1;GNB5;GNG2;STX1A;SLC6A4;SLC38A1;PPFIA4;KCNC1;KCNAB2;SYT7;KCNS3;KCNK6;SLITRK3;KCNAB3;SYT2;NRG1;GRIK5;SLC22A1;SIPA1L1;KCNN2;GRIN2B
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.1710520144458515,1.1292086861288995,0.3114754098360656,0.8879022078526032,1.0,23/59,26.49%,PIK3CD;MELK;PTK2;USP15;COQ8A;LMTK2;MAP4K5;BRSK1;CAB39;CREB1;ABI2;CDK6;NEK4;ATR;FNIP2;ERN1;TLK2;PRKAA2;NEK6;FAM20B;SYK;MAP3K9;PKDCC
prerank,TRRUST_Transcription_Factors_2019__NFKB1 mouse,0.26580254473702114,1.1214996659193086,0.3088235294117647,0.8984482966036214,1.0,11/17,36.83%,UBE2H;PLAUR;PPARA;TNFRSF25;MSX1;CD86;CDH1;AMH;FN1;PPP1R13L;APOE
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.18664330619396063,1.120064232178158,0.2905982905982906,0.8910600792789601,1.0,23/43,37.53%,PIK3CD;LPAR1;PTK2;USP15;NOD2;FNIP1;KSR1;NEK6;PLEKHG5;CD4;APOL3;F7;ERBB3;TSPAN6;CX3CL1;EDA2R;CD86;FGF1;UNC5CL;GPR62;HGF;FN1;BOK
prerank,KEGG_2021_Human__Tuberculosis,0.25703124999999993,1.1134573575010027,0.3333333333333333,0.8991174650313584,1.0,6/15,24.48%,CREB1;IRAK2;RAB7A;NOD2;KSR1;SYK
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,0.2031876138433516,1.11226819525345,0.2782608695652174,0.8911566543162974,1.0,15/35,27.64%,HIRA;CREB1;NUP210;CDK6;TNFRSF21;PARN;TFDP2;FNIP2;FNIP1;ERN1;BRIP1;TBL1X;PPARA;CBX2;PSMB9
prerank,MSigDB_Oncogenic_Signatures__KRAS.300 UP.V1 DN,-0.28776041666666674,-1.1109570927467318,0.32867132867132864,1.0,1.0,10/15,38.30%,DPYS;MAP2K6;OAS1;IFI44L;VILL;PDE11A;APBB3;CIITA;RTP4;NTF3
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.22039339395064017,1.1075778434678527,0.3333333333333333,0.8925398737055845,1.0,12/27,28.88%,LILRA2;MEGF8;VGLL4;PTPN2;WWP2;HERC4;NIBAN2;NOTCH3;ERBB3;CADM4;IGFBP3;CX3CL1
prerank,MSigDB_Oncogenic_Signatures__IL2 UP.V1 DN,-0.23838935574229692,-1.1056929591094198,0.32167832167832167,1.0,1.0,13/20,46.18%,DEPTOR;SULT1B1;ZNF571;MAP2K6;SDCCAG8;TNFAIP2;SNPH;VILL;COLQ;CLEC2B;TEK;RASGRP3;PBX1
prerank,MSigDB_Oncogenic_Signatures__STK33 SKM UP,-0.2266732375856566,-1.1049832232938595,0.368,1.0,1.0,15/23,44.94%,EVI5;TFPI;ZNF117;ZNF763;GPR137B;ZNF678;GPR132;TGFB1I1;TNFAIP2;MFAP3L;STOX2;CD9;RASGRP3;IL10RA;FCAMR
prerank,Reactome_2022__Innate Immune System R-HSA-168249,0.14817133443163102,1.1028399054929,0.2956521739130435,0.8936425181007025,1.0,28/81,27.64%,PTK2;ERP44;ARHGEF7;ACTR3;TRAF3;CAB39;CREB1;ABI2;PLAUR;CD33;IGF2R;SLC27A2;IRAK2;RAB7A;CPPED1;MEFV;NOD2;CD300A;MANBA;ATAD3B;CD53;SYK;MOSPD2;CD4;NFAM1;PADI2;CKAP4;PSMB9
prerank,KEGG_2021_Human__Human papillomavirus infection,0.19967506679182617,1.1002699769415116,0.3277310924369748,0.8905953119117745,1.0,17/36,32.28%,PIK3CD;DLG3;PTK2;RBL1;TRAF3;CREB1;CDK6;ATR;DLG1;ITGA3;NOTCH3;ITGA4;CRB3;COL9A2;AXIN2;ITGB5;COL4A5
prerank,MSigDB_Oncogenic_Signatures__PIGF UP.V1 UP,-0.23960784313725483,-1.1000254039506638,0.3053435114503817,1.0,1.0,9/20,26.41%,MAPK6;ZNF117;RNF13;ZNF451;NEK7;AHCYL2;REV3L;RAP1A;ZNF674
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,0.1885648246707825,1.0989295772528387,0.3333333333333333,0.8833723330700544,1.0,15/40,25.79%,AGPAT3;YWHAQ;RHOQ;COG5;RAB3GAP1;ACTR3;TJP1;IGF2R;RAB7A;CENPE;PRKAA2;FNBP1;SORT1;CD4;SPTBN2
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.25185008355216043,-1.0917860122259493,0.3310344827586207,1.0,1.0,6/17,15.83%,UVRAG;ORC4;TOP1MT;PDS5B;POLK;PRIM2
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,-0.16419205973951206,-1.0913885597778932,0.3383458646616541,1.0,1.0,50/69,54.21%,AKT3;POU2F1;APP;KPNA3;RAP1B;GSTA2;PTK2B;TEC;MAP2K6;OAS1;PIK3CB;NEDD4;PTPRJ;ZEB1;HCK;ITGAX;IL21R;HLA-B;CIITA;PML;STAT5A;PELI2;GRB10;OASL;DUSP4;HERC5;IRAK3;TNFSF14;VAV1;CD27;IL17RB;PTPN18;IL11RA;CD44;IL10RA;RORC;TRIM46;GRAP2;S1PR1;IFI6;IL12RB2;MMP2;TNFRSF14;GBP4;PRLR;MID1;FLNA;SIGIRR;IL13RA1;ANXA1
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,0.22545196738745119,1.090663954682895,0.3464566929133858,0.896729945442378,1.0,16/21,52.05%,AUH;MTAP;AASS;SMOX;SCLY;PAPSS1;FTCD;PSMB9;CHDH;PYCR1;PAH;SLC38A1;ASRGL1;IYD;BHMT;CDO1
prerank,WikiPathway_2021_Human__Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.2500959556471675,1.088451347965833,0.3391304347826087,0.8928207904363652,1.0,7/16,24.32%,CREB1;DLG1;CDH2;KSR1;PRKAA2;SORT1;IGF2BP1
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,0.23019361590790158,1.0877323441275215,0.30434782608695654,0.8836930834959934,1.0,16/21,50.73%,ARHGEF7;ABI2;RAB7A;DEPDC1B;ARHGAP12;ARHGAP39;ARHGEF18;CYBA;DLC1;SPATA13;IQGAP3;PLEKHG6;CDC42EP1;DOCK11;NOXA1;ARHGAP4
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,-0.15675617347054685,-1.0866483354909182,0.31386861313868614,1.0,1.0,34/89,29.88%,MUC6;STS;MBD5;USP37;NCOA1;NSMCE2;ADAMTS5;APP;BRCC3;EVA1A;AGBL3;TPST1;FBXO27;CNTN3;PROS1;TOMM70;INO80D;NR3C1;KLHL3;CREBBP;TNKS;PIGX;ADAM10;SHPRH;VNN1;ADAMTS2;AMFR;ALG6;ALG13;HIC1;ADAMTS9;PIGZ;RTN4RL1;BMP4
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,-0.14530600118835416,-1.0798571407511957,0.3597122302158273,1.0,1.0,39/107,29.96%,MUC6;STS;MBD5;USP37;NCOA1;NSMCE2;ADAMTS5;APP;BRCC3;MRPS9;EVA1A;AGBL3;TPST1;MYRIP;FBXO27;CNTN3;PROS1;TOMM70;INO80D;NR3C1;KLHL3;EXOC2;CREBBP;TNKS;PIGX;ADAM10;SHPRH;VNN1;ADAMTS2;AMFR;ALG6;ALG13;HIC1;ADAMTS9;SEC61A2;PIGZ;RTN4RL1;BMP4;INHBB
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.22490157480314962,-1.0787438074590259,0.3475177304964539,1.0,1.0,24/25,71.81%,ADAMTS5;APP;ADAMTS2;ITGA1;ADAMTS9;ITGAX;ADAMTSL5;COLQ;COL4A4;COL7A1;CD44;ADAMTSL2;MATN1;MMP2;ITGA2;COL9A3;SERPINE1;FN1;CDH1;COL4A5;ITGB5;COL9A2;ITGAL;ITGA4
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.22490157480314962,-1.0787438074590259,0.3475177304964539,1.0,1.0,24/25,71.81%,ADAMTS5;APP;ADAMTS2;ITGA1;ADAMTS9;ITGAX;ADAMTSL5;COLQ;COL4A4;COL7A1;CD44;ADAMTSL2;MATN1;MMP2;ITGA2;COL9A3;SERPINE1;FN1;CDH1;COL4A5;ITGB5;COL9A2;ITGAL;ITGA4
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.23963800904977373,-1.0743482208084376,0.3382352941176471,0.9963488763446737,1.0,9/20,30.19%,AKT3;TFPI;NEK7;RASA2;NR3C1;CDC42BPA;SIPA1L1;MAP2K5;PMP22
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.2456112852664577,-1.0733056646473103,0.3706896551724138,0.9827304604306643,1.0,12/19,43.09%,SLC2A10;RAP1B;SGK3;NEDD4;RAP1A;ZFYVE16;RASGRP2;HRG;IRAK3;IL17RB;LTBP4;SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.23416630208199288,1.0707809310139345,0.36363636363636365,0.9240193364588124,1.0,9/21,29.27%,MELK;PRMT2;TNFRSF10A;ARHGEF7;ING5;SYK;PLEKHG5;IGFBP3;ARHGEF18
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.22593453241359124,-1.0704609972014114,0.3252032520325203,0.9743310547859577,1.0,10/24,24.32%,TTC3;ATE1;BIRC6;RNF13;KLHL3;UBE3D;WWP1;NEDD4;RNF217;AMFR
prerank,MSigDB_Hallmark_2020__Apical Junction,0.2158167036215817,1.0663840114148952,0.376,0.926865494082403,1.0,14/24,39.38%,PTK2;TJP1;DLG1;ITGA3;SYK;THY1;CX3CL1;CRB3;CD86;CDH1;AMH;MAPK13;CDH15;SGCE
prerank,Elsevier_Pathway_Collection__Proteins Involved in Hearing Loss,-0.25039123630672927,-1.0656692575126623,0.35507246376811596,0.9728792369890912,1.0,17/17,75.37%,PDE5A;NR3C1;RB1;PMP22;NTF3;ANKRD35;KCNE1;KCNC1;MYO7A;TRPV1;PTGS2;COL9A3;APOE;COL4A5;SALL1;KCNJ10;ESPN
prerank,MSigDB_Oncogenic_Signatures__ERB2 UP.V1 DN,0.222920485292834,1.059292439166699,0.3706896551724138,0.9381193430124631,1.0,8/22,22.39%,HIRA;MSH2;CEBPZ;RALGAPA1;ATR;NCAPG;CENPE;HS2ST1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.22243885147110945,1.0584593703958518,0.3533834586466165,0.9293326616028523,1.0,14/21,41.08%,PIK3CD;PTK2;ELP3;ZNF304;TJP1;F7;SH3RF2;FGF1;CARMIL2;SEMA3G;HGF;CTSH;CAVIN1;BCAR1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.2111213896597801,-1.0579179072553588,0.3697478991596639,0.9796728980458308,1.0,11/26,27.10%,TRIM58;NSMCE2;BIRC6;ZNF451;KLHL3;WWP1;NEDD4;SHPRH;TRIM44;AMFR;ATG10
prerank,Elsevier_Pathway_Collection__Proteins Involved in Epilepsy,0.22181020949493852,1.05780243793033,0.36607142857142855,0.9211248744393158,1.0,15/21,48.88%,RALGAPA1;CREB1;PLAUR;IRAK2;KCNJ10;SPTBN2;CX3CL1;APOE;SLC6A4;DPYSL2;PTGS2;TRPV1;NAIP;CNN3;KCNC1
prerank,WikiPathway_2021_Human__Integrated breast cancer pathway WP1984,0.26447010869565213,1.057730743847736,0.3357142857142857,0.9112134700415588,1.0,5/15,17.22%,USP15;MSH2;RALGAPA1;CREB1;ATR
prerank,MSigDB_Oncogenic_Signatures__VEGF A UP.V1 UP,-0.2652057926829269,-1.0567858355680197,0.3591549295774648,0.9675663123632823,1.0,13/15,56.83%,ALDOB;ABHD3;PTPRJ;SHH;SMG6;KANK3;COLQ;DLG2;MMP2;TUB;OPTN;PPFIA4;TNNC2
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,-0.24309290083937973,-1.0555781083248204,0.3617021276595745,0.9561001152556413,1.0,6/17,19.61%,PLAAT3;SBF2;AGK;PLEKHA5;ABHD3;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.22990311599895255,1.0526689791480426,0.38095238095238093,0.9164954893634832,1.0,19/22,59.92%,PIK3CD;LILRA2;NOD2;SYK;CD4;NFAM1;CD86;MAPK13;SERPINE1;CYBA;ZFPM1;PTGS2;ANXA1;TNFRSF14;IL12RB2;CD2;CYP1B1;CD274;LRRFIP1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.2510804521276595,1.0519170783085585,0.3490566037735849,0.9088003111848422,1.0,6/15,24.02%,TAF4;TAF1B;GTF2E2;TBL1X;PPARA;NOTCH3
prerank,MSigDB_Oncogenic_Signatures__PKCA DN.V1 UP,-0.258995558365079,-1.0486433749201076,0.4406779661016949,0.9619301111043896,1.0,5/16,16.91%,CYP2C8;CREB3L2;SLC23A2;SGK3;GSTA2
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.20077473012617847,1.0458488765153742,0.4,0.9180622159105116,1.0,5/26,4.32%,PIK3CD;PHF2;YTHDF3;EPHX2;TAF1B
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.1796502384737679,1.0451075224025226,0.4016393442622951,0.9102561323872881,1.0,37/37,82.55%,SHB;PTK2;RHOQ;ARHGEF7;LMTK2;ACTR3;PTPN2;SORT1;SYK;CD4;ERBB3;FGF1;SHCBP1;HGF;CYBA;BCAR1;KLB;PRLR;MMP2;ZAP70;TEK;GALNT3;NTF3;VAV1;GRB10;SH2B2;EFNB2;BDKRB2;NRG1;HCK;FLRT2;SIPA1L1;PTPRJ;GRIN2B;PIK3CB;PAK2;PTK2B
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.23740219092331766,1.0423116569834536,0.3584905660377358,0.9081788333801486,1.0,7/17,23.17%,LMTK2;BRSK1;CAB39;ATR;ERN1;TLK2;NEK6
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.19552432995055943,-1.041260904268639,0.3684210526315789,0.9685237835984917,1.0,14/35,26.80%,TRIM58;BIRC6;FBXO27;RNF13;KLHL3;UBE3D;TNKS;WWP1;NEDD4;SHPRH;RNF217;TRIM44;AMFR;HECTD2
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.19242798207236989,-1.0408158653459338,0.38461538461538464,0.9552178979315874,1.0,32/34,72.43%,ADAMTS5;APP;ADAM10;ADAMTS2;ITGA1;FLRT2;ADAMTS9;ITGAX;COL26A1;ADAMTSL5;COLQ;COL4A4;COL7A1;CYP1B1;CD44;ADAMTSL2;MATN1;MMP2;QSOX1;A2M;ITGA2;HAS3;COL9A3;SERPINE1;FN1;CDH1;COL4A5;ITGB5;COL9A2;ITGAL;ITGA4;COL12A1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.17936507936507942,1.040796138027013,0.36885245901639346,0.903063201718449,1.0,35/35,82.55%,PTK2;LRP5;ZNF304;TJP1;CDK6;NOD2;PROX1;ERBB3;CX3CL1;CHRD;SAPCD2;CD86;FGF1;FN1;CTSH;TBX3;CCL14;FOSL1;IL13RA1;PRLR;IL12RB2;IL11RA;NTF3;EFNB2;NRG1;MEIS1;RBPMS2;BMP4;CCND2;ITGAX;HCK;SHH;NDUFS4;ADAM10;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.22707876370887337,1.0398385265084653,0.39316239316239315,0.896653120190748,1.0,10/20,31.81%,PTK2;LMTK2;PLAUR;FNIP1;PRKAA2;CD4;ERBB3;DRD4;AXIN2;FGF1
prerank,MSigDB_Oncogenic_Signatures__CSR LATE UP.V1 DN,-0.23671766761038487,-1.0364133385608045,0.373015873015873,0.954491952553487,1.0,10/18,36.29%,MAMDC2;PDE5A;SOD2;NTN4;ABCA6;OAF;NYNRIN;GLI3;DUSP4;EPSTI1
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,-0.1667093222315117,-1.0354787564769568,0.3798449612403101,0.943349452780931,1.0,13/48,20.54%,SLC35A3;ABCD3;SLC2A10;ATP11C;SLCO1A2;SLC36A4;SGK3;WNK3;ABCA6;SLC41A2;AHCYL2;SLC7A9;WWP1
prerank,KEGG_2021_Human__Insulin signaling pathway,0.2517898480737096,1.0326115318795988,0.3953488372093023,0.9072984819855263,1.0,7/16,26.02%,PIK3CD;PHKA2;RHOQ;ACACA;PRKAA2;G6PC1;PKLR
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.21561389116762375,1.0310435020938686,0.4,0.9030325846323367,1.0,22/23,73.05%,PTK2;CEP295;PPP1R16B;RAB3GAP1;PLAUR;FNIP1;CD4;AXIN2;FGF1;HGF;DLC1;SMPD1;SEMA4D;TEK;PELI2;NIBAN1;KNDC1;BMP4;CCND2;RAPGEF3;SLCO3A1;ATG10
prerank,MSigDB_Oncogenic_Signatures__STK33 SKM DN,0.19537526163659918,1.0288441819159904,0.43089430894308944,0.9000159443718582,1.0,7/25,16.14%,SNTB1;EPHX2;PPM1H;FAM117B;LILRA2;MCTP2;CYP4F3
prerank,KEGG_2021_Human__Shigellosis,0.25067223837209296,1.0283835917331605,0.41379310344827586,0.8923533449963462,1.0,13/15,56.68%,PIK3CD;PTK2;ACTR3;FNBP1;SEPTIN6;MAPK13;SEPTIN9;HK2;BCAR1;NAIP;HKDC1;PLCB4;CD44
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.21916732128829547,-1.02788465213853,0.4,0.9529629152314331,1.0,9/22,25.79%,TBC1D12;EVI5;RIC1;RABGAP1;AP3B1;TBC1D4;RABL3;IPO11;SNX13
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.2312170328452594,-1.0249441291056847,0.44274809160305345,0.9473687242727228,1.0,6/18,22.39%,CYP2C8;NCOA1;AHRR;CYP4V2;AADAC;CYP39A1
prerank,MSigDB_Oncogenic_Signatures__ERB2 UP.V1 UP,0.2312664625898768,1.0207063742722566,0.39285714285714285,0.903479233888564,1.0,8/18,29.81%,CHST11;LRP5;TNFRSF21;ETV5;HSD17B11;NOTCH3;SPTBN2;MAOA
prerank,MSigDB_Oncogenic_Signatures__P53 DN.V1 UP,0.21559839384195,1.0114899419999928,0.45614035087719296,0.9189092381251948,1.0,17/18,70.27%,MTAP;ZNF165;NDC80;PTPRH;LRIG1;FHL2;HDAC9;CPE;ITGA2;ANXA1;MYOF;CNN3;SLC16A2;CD9;EFNB2;INHBB;BMP4
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.24174408783783785,-0.9997851646022802,0.4603174603174603,1.0,1.0,13/15,60.00%,TGIF1;SOD2;TNFAIP2;CD83;STAT5A;DUSP4;FOSB;KLF4;CD44;FOSL1;PTGS2;SERPINE1;FOSL2
prerank,MSigDB_Oncogenic_Signatures__MEK UP.V1 UP,0.20846013390139986,0.9960016724917977,0.4715447154471545,0.9508767275198837,1.0,15/23,45.64%,CHST11;LRP5;TNFRSF21;ETV5;SPTBN2;MAP3K9;MAOA;SLC2A6;MAN1A1;SGCE;LGALSL;COTL1;DBNDD1;PACSIN3;FOSL1
prerank,KEGG_2021_Human__Rap1 signaling pathway,-0.20233515426636914,-0.9902165938624639,0.48031496062992124,1.0,1.0,17/27,44.86%,AKT3;PARD3;RAP1B;MAP2K6;PIK3CB;GRIN2B;SIPA1L1;RAP1A;RAPGEF3;RASGRP2;ADCY3;PARD6G;VAV1;TEK;RASGRP3;PLCB4;RASSF5
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.1960938584717915,0.9895015561573267,0.5075757575757576,0.959048905564396,1.0,23/24,74.90%,PTK2;PLAUR;FNIP2;FNIP1;CD4;CADM4;IGFBP3;AXIN2;FGF1;HGF;FN1;PRR5L;SEMA4D;TEK;HRG;PELI2;PML;NIBAN1;KNDC1;BMP4;CCND2;SLCO3A1;NDUFS4
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.17714968152866248,-0.9839990493734029,0.49624060150375937,1.0,1.0,10/39,13.98%,PLAAT3;ABCD3;BCAS3;WDPCP;ARHGAP10;MREG;ZNF135;ZNF501;ATL2;MTFR1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.23651290070367476,-0.9807031874392375,0.4852941176470588,1.0,1.0,7/16,26.64%,PLAAT3;BTD;VNN1;GLYAT;PLPP1;ACSM2B;SGPL1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.13558903920349696,0.9771035843711527,0.5,0.985184812233712,1.0,25/74,26.25%,ZNF124;ZNF669;ZGPAT;AASS;ZNF749;ZNF175;ZNF599;ETV5;ZNF557;MIER2;DLG1;FNIP2;WWP2;WWC2;FNIP1;ZNF778;BCOR;ZNF436;ZNF684;HDAC8;ZNF79;TBL1X;PPARA;PROX1;CBX2
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,-0.18526002745157846,-0.9770648533430549,0.5037593984962406,1.0,1.0,29/31,72.43%,ADAMTS5;NTN4;ADAM10;ADAMTS2;ITGA1;ADAMTS9;ITGAX;BMP4;PCOLCE;COL26A1;COL4A4;LTBP4;COL7A1;CD44;MATN1;SDC3;MMP2;ITGA2;P3H3;COL9A3;SERPINE1;FN1;COL4A5;ITGB5;COL9A2;ITGAL;FBN3;ITGA4;COL12A1
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,0.23537202214740466,0.973660134296528,0.49606299212598426,0.9849064499578729,1.0,5/16,17.45%,PTK2;ACTR3;CREB1;ABI2;MEFV
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.21131186174391203,-0.9734617496900494,0.4489795918367347,1.0,1.0,9/22,29.88%,SLC2A10;APP;MYOM1;DTNBP1;PIK3CB;MAP2K5;ATAD1;ITGAX;BMP4
prerank,MSigDB_Oncogenic_Signatures__ESC J1 UP LATE.V1 UP,0.20507637017070973,0.9716673189062802,0.4830508474576271,0.9813102681262657,1.0,17/23,49.58%,LMO7;RNF130;AMN;CTSH;FHL2;SGCE;ZFPM1;KLB;SOAT2;MYO7A;MOGAT2;TUFT1;CDC42EP1;HKDC1;RBP4;S100G;ZDHHC9
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,-0.21464052287581703,-0.971634555470258,0.44,1.0,1.0,8/20,23.32%,NCOA1;TTBK2;EXOC2;CREBBP;CHCHD3;CEP63;LIN9;SDCCAG8
prerank,Elsevier_Pathway_Collection__Proteins Involved in Endometriosis,0.19586803765701727,0.9700979364831716,0.4909090909090909,0.9768902095502481,1.0,21/24,61.93%,PTK2;TNFRSF21;IGFBP3;FGF1;CDH1;AMH;HGF;LGALS3;IL1RN;SERPINE1;RRM2;DPYSL2;PTGS2;ANXA1;TIMP3;MMP2;CD44;CD163;VDR;NTF3;VAV1
prerank,MSigDB_Oncogenic_Signatures__P53 DN.V2 UP,-0.2349330357142858,-0.9651233310266895,0.45112781954887216,1.0,1.0,3/15,5.33%,CYP2C8;DPYS;C4BPA
prerank,MSigDB_Hallmark_2020__Complement,0.23624413145539905,0.959423684847304,0.4789915966386555,0.9963583618365823,1.0,11/17,40.69%,USP15;PLAUR;AKAP10;CASP7;F7;PSMB9;FN1;CTSH;LGALS3;GNG2;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.21015175300889588,0.9580092083033444,0.5042016806722689,0.9906590160814311,1.0,4/21,5.87%,MELK;PRMT2;TNFRSF10A;ARHGEF7
prerank,MSigDB_Oncogenic_Signatures__EGFR UP.V1 UP,0.2039863115057344,0.957105102826805,0.5378151260504201,0.9840222129775797,1.0,15/23,47.57%,RHOQ;SLC4A7;TNFRSF21;ETV5;FNDC3B;ITGA3;CASP7;PSMB9;MAOA;HK2;COTL1;CYP27B1;ITGA2;A2M;GK
prerank,KEGG_2021_Human__Proteoglycans in cancer,0.2159526297457332,0.9550111375191979,0.5081967213114754,0.9806788155620676,1.0,14/19,50.97%,PIK3CD;PTK2;PPP1R12A;PLAUR;DROSHA;ERBB3;ITGB5;MAPK13;HGF;FN1;ITGA2;TIMP3;FLNA;MMP2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.20246498599439777,0.950447926807087,0.5089285714285714,0.9836051530158523,1.0,8/20,27.57%,ING5;TTC23;NOD2;DEPDC1B;ERN1;RWDD3;F7;SALL1
prerank,Elsevier_Pathway_Collection__Melanoma,0.23463541666666665,0.9499036547720827,0.5867768595041323,0.9765280745149049,1.0,5/15,18.38%,PTK2;CREB1;PLAUR;CDK6;CDH2
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.1968503937007874,-0.9470923202394981,0.5615384615384615,1.0,1.0,11/25,30.66%,EVI5;RIC1;RABGAP1;CCL23;BCAS3;GPR137B;SIPA1L1;RAP1A;SNX13;RAPGEF3;RASGRP2
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.2276064860454839,0.9465238877233204,0.5081967213114754,0.9767640179511636,1.0,8/16,31.81%,PIK3CD;PTK2;PPARA;F7;ERBB3;CX3CL1;CD86;FGF1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.22115259317174876,0.9441517336551895,0.5045871559633027,0.9740529196427505,1.0,6/16,25.95%,PRMT2;TRAF3;IRAK2;WWP2;RWDD3;PROX1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.21657544956997654,-0.9394454788665395,0.5206611570247934,1.0,1.0,16/16,78.69%,PARD3;DEPTOR;DTNBP1;PAK2;RB1;NIBAN1;NTF3;SEMA4D;PRR5L;SAMSN1;DBNDD1;GPD1L;IGFBP3;CADM4;THY1;CEP85
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.17873552767169787,0.936815388719441,0.5254237288135594,0.9849095228211329,1.0,24/26,70.27%,TNFRSF10A;TNFRSF21;TNFRSF25;CD4;CX3CL1;EDA2R;AMH;IL1RN;IL17C;TNFRSF10D;CCL14;IL13RA1;PRLR;TNFRSF14;IL12RB2;IL10RA;IL11RA;CCL27;IL17RB;CD27;TNFSF14;IL21R;INHBB;BMP4
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.15262544063110176,0.9366698018473693,0.5583333333333333,0.9770405139268542,1.0,40/44,72.28%,PTK2;SMC5;LRP5;LILRA2;TJP1;ACACA;PRKAA2;PROX1;ERBB3;CX3CL1;CHRD;SAPCD2;AXIN2;CD86;FGF1;PRR7;FN1;PPP1R13L;CTSH;CYBA;TBX3;CCL14;FOSL1;IL13RA1;TUB;PRLR;NOXA1;IL12RB2;IL11RA;NTF3;EFNB2;SLFN11;NRG1;MEIS1;BMP4;CCND2;ECHDC3;ITGAX;HCK;SHH
prerank,WikiPathway_2021_Human__Insulin Signaling WP481,-0.22906885758998438,-0.9362074064037877,0.5111111111111111,1.0,1.0,11/17,40.00%,MAPK6;SGK3;MAP2K6;TBC1D4;PIK3CB;MAP2K5;LIPE;SH2B2;GRB10;MAPK4;MAP4K1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.20213289077386443,0.9349250735984148,0.6033057851239669,0.9735461833159865,1.0,18/19,72.28%,PIK3CD;NIBAN2;SYK;NFAM1;AXIN2;ELOVL6;APOE;SERPINE1;CYP27B1;PRLR;PAX8;VDR;GRB10;INHBB;BMP4;TGFB1I1;ITGAX;SHH
prerank,WikiPathway_2021_Human__Vitamin D Receptor Pathway WP2877,0.21184595495679387,0.9347524165901093,0.5403225806451613,0.9663019580720854,1.0,15/17,61.78%,LRP5;TRAK1;CLEC16A;CBS;IGFBP3;CYP2S1;ASAP2;CYP27B1;NFATC2;TIMP3;S100G;KLF4;VDR;ADGRE5;CD9
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.21120569884052848,-0.9326596860506168,0.5666666666666667,1.0,1.0,7/18,24.32%,FBXO27;DNAJB14;UBE3D;RB1;WWP1;NEDD4;AMFR
prerank,MSigDB_Oncogenic_Signatures__AKT UP MTOR DN.V1 UP,-0.21676309616888192,-0.9315606973889679,0.5036496350364964,1.0,1.0,8/16,34.59%,TGIF1;MLLT1;ADAM10;PTPRJ;SGPL1;HCK;VILL;EFNB2
prerank,KEGG_2021_Human__Yersinia infection,0.2149191444966093,0.9279598349280549,0.5565217391304348,0.9741232501396766,1.0,4/17,8.34%,PIK3CD;PTK2;ARHGEF7;ACTR3
prerank,Elsevier_Pathway_Collection__Proteins Involved in Atherosclerosis,0.2215207193119625,0.9276410137535612,0.5403225806451613,0.9668344102445829,1.0,11/16,45.64%,PLAUR;CD4;ITGA4;CX3CL1;FGF1;HGF;FN1;APOE;SERPINE1;PTGS2;FOSL1
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.22291666666666674,-0.9261619685031532,0.5873015873015873,1.0,1.0,5/15,19.61%,AKT3;CREB3L2;CREBBP;MAP2K6;PIK3CB
prerank,MSigDB_Oncogenic_Signatures__NFE2L2.V2,0.16625302753939536,0.9261102274724022,0.5166666666666667,0.9631831095382632,1.0,17/33,35.68%,ZNF326;CDC45;SMC5;CYP4F3;ZSWIM6;BRIP1;NLN;PTGR1;SYK;CBS;CKAP4;SLC47A1;IGFBP3;AXIN2;NR1I2;SEMA3G;ZNF430
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,0.17722056948576292,0.9248568862637943,0.5826086956521739,0.9585814823836836,1.0,8/28,17.68%,ST3GAL1;YWHAQ;DAD1;TRAF3;NUP210;TJP1;IRAK2;NOD2
prerank,WikiPathway_2021_Human__PI3K-Akt signaling pathway WP4172,0.17390896852580823,0.9243185807856894,0.5714285714285714,0.9518589640165476,1.0,24/33,51.97%,PIK3CD;LPAR1;PTK2;CREB1;CDK6;ITGA3;PRKAA2;SYK;ITGA4;COL9A2;ITGB5;FGF1;COL4A5;HGF;FN1;GNB5;GNG2;COL9A3;ITGA2;PIK3AP1;PRLR;CREB5;THBS4;PIK3R6
prerank,MSigDB_Oncogenic_Signatures__RPS14 DN.V1 UP,-0.19691018591254258,-0.9235539341318698,0.5307692307692308,1.0,1.0,19/22,63.24%,CDCP1;VNN1;GPR137B;HCK;ITGAX;TNFAIP2;NYNRIN;CD9;CLEC2B;RASGRP3;CYP1B1;GFI1;MS4A6A;MNDA;FRY;RIN2;LY75;CTSH;GNB5
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.18549358470803862,0.915781946737922,0.5645161290322581,0.9645649238814921,1.0,21/22,75.14%,SP110;RAPGEF6;PTPN2;CASP7;PSMB9;CD86;PTGS2;GBP4;IL10RA;C1R;CD274;RTP4;HERC6;EPSTI1;OASL;PML;CIITA;HLA-B;TNFAIP2;APOL6;IFI44L
prerank,MSigDB_Oncogenic_Signatures__KRAS.600.LUNG.BREAST UP.V1 UP,-0.20413977556834706,-0.9156611849543441,0.5327868852459017,1.0,1.0,18/21,61.54%,TFPI;DCBLD2;ATG10;HIC1;KCNAB3;FAM174B;TRIM46;KCNC1;RBP4;FAM120C;GFI1;A2M;ITGA2;PTGS2;TBX3;COL9A3;STX1A;HDAC9
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.20814408770555992,-0.9128570955030723,0.5555555555555556,1.0,1.0,6/18,19.46%,AKT3;TTBK2;VRK2;SGK3;TNKS;PAK2
prerank,MSigDB_Oncogenic_Signatures__SNF5 DN.V1 UP,0.20068456134029902,0.9082029014705985,0.5661764705882353,0.9750642549881524,1.0,8/21,27.64%,LRP5;USP15;RBL1;CD53;FNBP1;KCNJ10;CD48;PSMB9
prerank,MSigDB_Oncogenic_Signatures__PTEN DN.V1 UP,0.2249999999999999,0.9058350339259886,0.5416666666666666,0.9729568827311018,1.0,15/15,77.76%,ACSS3;MEFV;ZNF22;PRDM14;CYB5R2;FGF1;MAN1A1;SLC30A10;KANK3;CD27;RTP4;NYNRIN;INHBB;PTPRJ;CYP39A1
prerank,WikiPathway_2021_Human__IL-18 signaling pathway WP4754,0.21584302325581392,0.9011780790537205,0.55,0.9763658756373065,1.0,4/15,15.75%,SNTB1;GPAT4;SLC4A7;PLD1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.22311839018970414,-0.9007074157769631,0.6142857142857143,1.0,1.0,15/16,67.57%,PLAAT3;AMFR;CD9;IL17RB;PRSS23;KLF4;CD44;PRLR;HPRT1;MYOF;CPE;SERPINA5;MAPK13;CDH1;SLC2A8
prerank,WikiPathway_2021_Human__Epithelial to mesenchymal transition in colorectal cancer WP4239,0.19823601296424206,0.9004113009331572,0.5737704918032787,0.9705046025173917,1.0,12/19,39.85%,PIK3CD;LRP5;TJP1;CDH2;NOTCH3;PROX1;CRB3;COL4A5;CDH1;MAPK13;FN1;FMNL2
prerank,MSigDB_Oncogenic_Signatures__STK33 NOMO UP,0.20866477272727274,0.8998113390201504,0.5775862068965517,0.9646586555592911,1.0,3/15,6.56%,AUH;ST3GAL1;FNDC3A
prerank,KEGG_2021_Human__Huntington disease,-0.2026347234720522,-0.8987059826935679,0.5354330708661418,1.0,1.0,6/16,25.25%,DNAH14;CREB3L2;CREBBP;SOD2;GRIN2B;NDUFS4
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,0.20641627543035995,0.8974707001667744,0.6086956521739131,0.9626929005086848,1.0,15/17,61.93%,ARHGEF7;DEPDC1B;PLEKHG5;ARHGAP39;ARHGEF18;RHPN2;ANLN;CAVIN1;DLC1;IQGAP3;PLEKHG6;ARHGAP4;ARHGAP20;FMNL3;VAV1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.18639980708946233,0.8943234697951238,0.5833333333333334,0.9631813583057981,1.0,18/19,73.98%,CD33;TNFRSF21;MEFV;PPARA;CX3CL1;HOMER3;FN1;HDAC9;ZFPM1;ANXA1;SIGIRR;KLF4;CD274;C5AR2;IRAK3;HERC5;INHBB;MAP2K5
prerank,WikiPathway_2021_Human__Focal Adhesion WP306,-0.18877889981397822,-0.8896464303055752,0.5602836879432624,1.0,1.0,9/23,29.27%,AKT3;RAP1B;PAK2;PIK3CB;ITGA1;RAP1A;TESK2;HCK;CCND2
prerank,MSigDB_Oncogenic_Signatures__PTEN DN.V2 UP,0.2203124999999999,0.8895694041952376,0.5944055944055944,0.9662131870781693,1.0,15/15,78.22%,ANKMY1;APOL3;CD86;ULK4;SERPINA5;MPV17;TNFRSF10D;PTGS2;THBS4;GNA14;IL11RA;SLITRK3;LIPG;AGPAT4;VPS13C
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.14083448913546004,-0.8890537506078388,0.6097560975609756,1.0,1.0,48/59,63.63%,A1BG;APP;NHLRC2;TFPI;RAP1B;PDE5A;PROS1;CARMIL1;TNFRSF10B;PIK3CB;SLC7A9;ITGA1;RAP1A;GLG1;ITGAX;RAPGEF3;SLC7A8;RASGRP2;PDE11A;SH2B2;HRG;VAV1;CD9;TEK;PROCR;GNA14;CD44;IRAG1;FCAMR;SDC3;CD2;PIK3R6;LAMP2;DOCK11;QSOX1;FLNA;TIMP3;ITGA2;TNFRSF10D;BCAR1;ZFPM1;SERPINE1;KIF3B;SERPINA5;GNG2;KIF23;GNB5;FN1
prerank,MSigDB_Oncogenic_Signatures__LTE2 UP.V1 UP,-0.20017811353202203,-0.8888535057713561,0.5693430656934306,1.0,1.0,4/18,11.58%,SLC2A10;SGPP1;CREB3L2;PROS1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.19033731894624284,-0.8886075947799901,0.584,1.0,1.0,8/25,20.77%,TBC1D12;EVI5;RIC1;RABGAP1;AP3B1;TANGO6;TBC1D4;RABL3
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.16273290969796755,-0.8866371526344403,0.5877862595419847,1.0,1.0,14/33,31.66%,APP;WNK3;PTK2B;TEC;PAK2;PTPRJ;RAP1A;SLCO3A1;RAPGEF3;CCND2;BMP4;INHBB;KNDC1;NIBAN1
prerank,KEGG_2021_Human__Endocytosis,0.20464668351992296,0.8855841967210124,0.5663716814159292,0.9675600747197034,1.0,5/17,18.15%,ACTR3;IGF2R;RAB7A;PLD1;ACAP2
prerank,MSigDB_Oncogenic_Signatures__CAMP UP.V1 DN,0.20555120508135394,0.8832702041473334,0.6065573770491803,0.9653119392536242,1.0,17/18,70.89%,RALGAPA1;TJP1;CASP7;DPYSL3;GLS;ASAP2;FRY;NFATC2;MS4A6A;MPZL3;ANXA1;LRRFIP1;FOSB;SEL1L3;NYNRIN;CD83;CCND2
prerank,Reactome_2022__Disease R-HSA-1643685,0.11095568522649835,0.883195501516867,0.6788990825688074,0.9584574975616473,1.0,37/126,25.10%,PTK2;ST3GAL1;TCEA1;SLC20A2;TAF4;LRP5;YWHAQ;MSH2;TRIM24;GTF2E2;DAD1;RPIA;LMO7;MAP4K5;ACTR3;TRAF3;CREB1;ABI2;NUP210;TJP1;CDK6;TRAK1;IRAK2;RAB7A;TFDP2;MEFV;NOD2;ACACA;KSR1;BRIP1;PAPSS1;HDAC8;TBL1X;NOTCH3;G6PC1;SYK;CD4
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.17741492110616305,0.8819916501555224,0.5818181818181818,0.9542835603298037,1.0,6/26,10.42%,TCEA1;TAF4;TRIM24;GTF2E2;GTF2I;ZNF473
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.1952408618991083,-0.8779522115569096,0.5827338129496403,1.0,1.0,6/18,19.46%,PEAK1;VRK2;WNK3;PTK2B;TEC;PAK2
prerank,KEGG_2021_Human__Cell adhesion molecules,0.22017564594432423,0.8748488430162521,0.6475409836065574,0.9630210788392245,1.0,9/16,36.37%,CDH2;CNTNAP1;CD4;LRRC4;ITGA4;ITGAL;CD86;CDH1;CDH15
prerank,MSigDB_Oncogenic_Signatures__BMI1 DN.V1 UP,0.2132237871674491,0.8723410411361348,0.6306306306306306,0.9611096792797139,1.0,3/17,3.86%,SLC19A1;CHST11;LRP5
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.180298273155416,0.8645883155789015,0.6271186440677966,0.9704615851986825,1.0,11/21,37.22%,DLG3;PTK2;DLG1;KSR1;SPTBN2;ERBB3;PSMB9;FGF1;MAPK13;HGF;CTSH
prerank,MSigDB_Oncogenic_Signatures__GCNP SHH UP EARLY.V1 DN,-0.21588541666666666,-0.86409369193799,0.5857142857142857,1.0,1.0,3/15,5.33%,STS;BTD;C4BPA
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.19926087733036585,0.8624990472976934,0.6124031007751938,0.9674735433532519,1.0,4/18,8.34%,CDC14B;CEP164;NUDCD3;ACTR3
prerank,MSigDB_Oncogenic_Signatures__PRC2 EZH2 UP.V1 UP,0.20247068021892106,0.8621622857492421,0.6428571428571429,0.9614959105638845,1.0,3/16,3.94%,CDC45;EPHX2;LIN7A
prerank,WikiPathway_2021_Human__EGF/EGFR signaling pathway WP437,-0.21229221198626647,-0.8545982507582874,0.6031746031746031,1.0,1.0,10/16,40.00%,PTK2B;NEDD4;RAP1A;MAP2K5;STAT5A;GRB10;MAPK4;VAV1;FOSB;MAP4K1
prerank,Elsevier_Pathway_Collection__Receptors and Adaptor Proteins Activated in Cancer,0.2091546474358974,0.854350026711046,0.6776859504132231,0.971822293561238,1.0,14/15,69.11%,PTK2;PLAUR;SYK;ERBB3;FGF1;HGF;ZAP70;IL11RA;NTF3;VAV1;GRB10;EFNB2;STAT5A;NRG1
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.1433714295604414,-0.8513713856512087,0.6,1.0,1.0,25/48,41.54%,AKT3;RAP1B;PTK2B;TEC;PIK3CB;WWP1;GRIN2B;ADAM10;NEDD4;PTPRJ;RAP1A;MAP2K5;FLRT2;NRG1;STAT5A;SH2B2;GRB10;DUSP4;VAV1;NTF3;FOSB;COL4A4;PTPN18;GALNT3;CD274
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.20165647975905754,-0.8502054458640393,0.6482758620689655,1.0,1.0,6/17,25.33%,PLAAT3;ALDOB;AGK;PAK2;PIK3CB;PLPP1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.16576150618703814,0.8490880042020013,0.626984126984127,0.9769913856102044,1.0,11/26,32.28%,PPP1R9A;CLIP2;CD2AP;PLOD2;DLG1;ARHGAP12;COL12A1;CAMSAP3;COL9A2;SHROOM1;COL4A5
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.1333874458874459,-0.8480738267847783,0.6507936507936508,1.0,1.0,58/63,75.68%,POU2F1;CCL23;RAP1B;GSTA2;SOD2;PTK2B;TEC;OAS1;PAK2;PIK3CB;PTPRJ;ZEB1;HCK;ITGAX;IL21R;HLA-B;CIITA;PML;STAT5A;PELI2;GRB10;OASL;IRAK3;TNFSF14;VAV1;CD27;IL17RB;IL11RA;CD44;SPI1;IL10RA;RORC;GRAP2;S1PR1;IFI6;IL12RB2;MMP2;TNFRSF14;PRLR;MID1;IL13RA1;ANXA1;CCL14;PTGS2;IL17C;STX1A;IL1RN;GPR35;FN1;HGF;CD86;EDA2R;MAOA;CX3CL1;PSMB9;CD4;TNFRSF25;SYK
prerank,Reactome_2022__Signal Transduction R-HSA-162582,0.09641598457471932,0.8458245972793489,0.6822429906542056,0.9769764716569357,1.0,68/192,32.28%,SHB;LPAR1;PTK2;MRTFA;SENP1;CENPA;TNFRSF10A;LRP5;PPP1R12A;USP15;YWHAQ;RHOQ;RBL1;ARHGEF7;PKP4;RALGAPA1;ACTR3;SMOX;CAB39;CREB1;ABI2;SLC4A7;TJP1;TRAK1;RAB7A;RBBP6;TFDP2;DLG1;PTPN2;NDC80;WWP2;DEPDC1B;AATF;KSR1;CENPE;ITGA3;NLN;PRKAA2;HDAC8;FNBP1;ARHGAP12;TBL1X;NOTCH3;IGF2BP1;SYK;MOSPD2;PLEKHG5;ARHGAP39;BAIAP2L2;SPTBN2;CBX2;CKAP4;MYCN;ERBB3;PSMB9;CX3CL1;ARHGEF18;ERCC6L;COL9A2;PDK3;PLPPR1;DRD4;AXIN2;ITGB5;CD86;FGF1;ZFYVE9;COL4A5
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,0.1315023525549842,0.8450108367082002,0.7264957264957265,0.9723413927025771,1.0,24/60,31.58%,UBE2H;ARHGEF7;TPP2;LMO7;LILRA2;HERC2;CD33;RAB7A;RBBP6;CD300A;RNF130;CENPE;HERC4;SYK;CD4;SPTBN2;FBXO31;PSMB9;SIGLEC7;ITGA4;ITGAL;DAPP1;ITGB5;CD86
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.1663075010360547,-0.8413682177300214,0.6183206106870229,1.0,1.0,5/25,9.96%,TBC1D12;EVI5;RIC1;RABGAP1;AP3B1
prerank,MSigDB_Oncogenic_Signatures__PRC2 EDD UP.V1 DN,0.18726082652443077,0.8401077497268027,0.6153846153846154,0.9753523612547601,1.0,3/18,4.09%,SLC35D2;CHST11;PPM1H
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.20547609192230448,0.8399117726592948,0.6333333333333333,0.9692379918949443,1.0,6/16,24.71%,ZNF304;ABI2;PLD1;RAPGEF6;KSR1;PLEKHG5
prerank,Elsevier_Pathway_Collection__Proteins Involved in Prostate Cancer,-0.2033726633022958,-0.835977575177213,0.6642335766423357,1.0,1.0,11/16,50.42%,NR3C1;PTK2B;PIK3CB;RB1;TGFB1I1;STAT5A;VDR;CD44;TMPRSS2;MMP2;PRLR
prerank,KEGG_2021_Human__Axon guidance,-0.19226251430636704,-0.8315874673460226,0.6642335766423357,1.0,1.0,12/18,48.42%,NEO1;PARD3;NTN4;PAK2;PIK3CB;SHH;EFNB2;PARD6G;BOC;SEMA4D;ABLIM3;SLIT3
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.1425285768553372,0.829647471050584,0.7109375,0.9839525294165007,1.0,13/36,28.57%,THAP12;DLG3;DIS3L2;CD33;CDK6;ING5;VGLL4;CD300A;PTPN2;NIBAN2;PROX1;CGREF1;IGFBP3
prerank,MSigDB_Oncogenic_Signatures__GCNP SHH UP LATE.V1 DN,0.18601508038127756,0.8270855102006391,0.6302521008403361,0.9823608101792227,1.0,5/17,17.92%,SLC19A1;NDUFA10;TTC23;RBBP6;ARID3A
prerank,KEGG_2021_Human__Hippo signaling pathway,0.1961890243902439,0.821974833013973,0.7033898305084746,0.9873513193837448,1.0,14/15,70.89%,DLG3;YWHAQ;DLG1;AXIN2;FGF1;CDH1;AMH;SERPINE1;TEAD4;DLG2;PARD6G;DCHS1;BMP4;CCND2
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,0.17321288295365278,0.8219658575259261,0.6592592592592592,0.9809399471799543,1.0,9/22,27.64%,UBE2H;TPP2;LMO7;HERC2;RBBP6;RNF130;HERC4;FBXO31;PSMB9
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.18559122944400935,0.8209944748807104,0.6902654867256637,0.9763947575019627,1.0,18/18,81.70%,PIK3CD;PTK2;NIBAN2;NOTCH3;SPTBN2;SEMA3G;PTPRM;SLIT3;DAB1;SEMA4D;DSCAML1;GRB10;RHOH;EFNB2;FEZ1;SHH;PIK3CB;NTN4
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.17825870292589166,-0.8194269175312867,0.7286821705426356,1.0,1.0,12/18,46.18%,POLK;KDM6A;MLLT1;ZEB1;CCND2;MEIS1;ETV7;PML;PAX8;SPI1;TMPRSS2;PBX1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.18868341435224525,0.8184447439811647,0.6942148760330579,0.975420796843832,1.0,11/16,44.48%,ARHGEF7;ITGA3;THY1;ITGA4;ITGAL;ITGB5;FN1;HOXD3;SGCE;DLC1;ITGA2
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.19336854460093889,0.8170201169768065,0.7049180327868853,0.9720498151601017,1.0,14/17,58.07%,MEFV;NOD2;PTPN2;PPARA;CX3CL1;MAPK13;APOE;SERPINE1;PTGS2;ANXA1;PIK3AP1;FNDC4;TEK;KLF4
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.19004321471040347,-0.8148457064768446,0.674074074074074,1.0,1.0,12/18,46.18%,BTD;WWP1;GRIN2B;NDUFS4;SHH;MEIS1;ADGRA2;EML1;POU6F1;PAX8;DSCAML1;PBX1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.20807291666666675,-0.8141645121519214,0.696969696969697,1.0,1.0,5/15,21.08%,SLC2A10;APP;ZNF148;RB1;ADAM10
prerank,MSigDB_Oncogenic_Signatures__LEF1 UP.V1 DN,-0.1787269334439146,-0.8132427986136086,0.6739130434782609,1.0,1.0,19/21,67.49%,MYRIP;PROS1;OAS1;VILL;GALC;BDKRB2;EFNB2;HERC6;IL17RB;ENTPD3;CYP1B1;RBP4;CNN3;GSTM3;RNF144A;CPE;CTSH;DPYSL3;ACSL5
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.19777057926829267,0.8086230828855833,0.7295081967213115,0.9824726839103965,1.0,11/15,48.80%,ANKRD11;PAPSS1;PKDCC;CHRD;COL9A2;HOXD3;SNORC;DLX6;TBX3;TEAD4;RBP4
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.1933741840464025,0.8049053353633939,0.7295081967213115,0.9838274932614556,1.0,12/16,50.73%,SRGAP2B;THY1;IGFBP3;CX3CL1;CHRD;CDH1;MCTP1;DPYSL3;SERPINE1;DLC1;STK26;ARHGAP4
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.1305734265734266,-0.8047351732129345,0.6940298507462687,1.0,1.0,16/45,29.88%,APP;CCL23;PDS5B;DCBLD2;ARID2;SOD2;PTK2B;RB1;ADAM10;VPS13C;PTPRJ;ITGA1;PLPP1;SHH;TGFB1I1;BMP4
prerank,KEGG_2021_Human__Alzheimer disease,-0.19424897923725135,-0.8047157910825194,0.697841726618705,1.0,1.0,6/16,25.25%,AKT3;APP;PIK3CB;GRIN2B;ADAM10;NDUFS4
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.18825848998878197,0.8037031414198962,0.7107438016528925,0.9801943773944239,1.0,15/16,72.74%,PTK2;MEGF8;BCOR;ERBB3;SALL1;FN1;HDAC9;ZFPM1;DLC1;RBP4;TEK;POU6F1;BMP4;SHH;FLRT2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.1652276295133438,0.8024589298719724,0.7207207207207207,0.9767268839963045,1.0,4/21,8.65%,PIK3CD;PTK2;LMTK2;BRSK1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.17392156862745095,-0.7958428195271452,0.6984126984126984,1.0,1.0,4/20,7.88%,EVI5;RIC1;CCL23;BCAS3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.1968749999999999,0.7928875348052358,0.725,0.9871628942315658,1.0,15/15,80.54%,PIK3CD;PTK2;F7;ERBB3;CX3CL1;CD86;FGF1;HGF;KLB;PIK3AP1;TEK;VAV1;NRG1;PTPRJ;PIK3CB
prerank,MSigDB_Oncogenic_Signatures__KRAS.DF.V1 DN,0.1762117193151677,0.7913544352862348,0.75,0.984022478629773,1.0,18/19,74.98%,TAF4;COG5;ERN1;IGFBP3;SF3A2;COL4A5;HDAC9;TCFL5;LRRC61;PTGS2;MOGAT2;TUFT1;SYNE1;CD2;KLF4;HRH2;BMP4;ALG13
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.18318333501870768,0.7901768175845549,0.7105263157894737,0.9798557822923492,1.0,11/19,36.83%,CDK6;MEGF8;MEFV;SORT1;IGF2BP1;PRDM14;PROX1;IGF2BP3;CDH1;PCBP4;APOE
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.17514222686636477,0.785905372315107,0.7109375,0.9821177427440022,1.0,18/19,75.37%,LRP5;CREB1;CDH2;PKDCC;IGFBP3;AXIN2;HGF;CDH15;PPP1R13L;HOXD3;RIN2;ZC4H2;PAX8;BOC;BMP4;TGFB1I1;ZEB1;RAP1A
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.15685949728767232,0.7793193605708194,0.7697841726618705,0.9870110466002016,1.0,6/24,16.06%,CDC14B;CEP164;NUDCD3;ACTR3;HAUS2;HAUS8
prerank,Elsevier_Pathway_Collection__Proteins with Altered Expression in Cancer-Associated Sustaining of Proliferative Signaling,0.18516409197693454,0.7787738403735018,0.7310924369747899,0.9820010531453868,1.0,7/18,27.10%,PTK2;PLAUR;CDK6;ATR;NOTCH3;SYK;ERBB3
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.15367544567529895,0.7757063944284404,0.7355371900826446,0.9816695086033174,1.0,6/27,12.74%,CDC14B;CEP164;ARHGEF7;NUDCD3;ACTR3;CD2AP
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.18859134740682823,0.7754373475905599,0.7307692307692307,0.9762912641536111,1.0,6/16,27.10%,MELK;TNFRSF10A;TNFRSF21;CASP7;TNFRSF25;ERBB3
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.16303879583407244,-0.7738590543257594,0.736,1.0,1.0,18/22,61.54%,EVI5;TFPI;DCBLD2;SDCCAG8;ATG10;CCND2;ADGRA2;MAP4K1;GALNT3;KLF4;IL10RA;AMMECR1;RBP4;HKDC1;ITGA2;PTGS2;CPE;HDAC9
prerank,MSigDB_Hallmark_2020__Glycolysis,0.1809591935188728,0.7735679123570351,0.7711864406779662,0.9738005572714283,1.0,13/16,56.68%,PHKA2;CENPA;PLOD2;HS2ST1;IGFBP3;PDK3;DEPDC1;HK2;PPFIA4;IL13RA1;QSOX1;SDC3;CD44
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.14476995217976696,-0.7730248032341723,0.8015267175572519,1.0,1.0,10/28,30.42%,SLC35A3;SLC2A10;SLCO1A2;SLC36A4;SLC41A2;AHCYL2;SLC7A9;SLC22A1;SLCO3A1;SLC7A8
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,-0.11468376620381049,-0.7714651404026592,0.8013245033112583,1.0,1.0,18/68,22.78%,PLAAT3;CYP2C8;SBF2;GGT5;STS;NCOA1;AHRR;SGPP1;AGK;PLEKHA5;SLCO1A2;ABHD3;CREBBP;CDK19;PIK3CB;HACD2;CYP39A1;LIN9
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.1833316684979856,-0.7693789972748982,0.7943262411347518,1.0,1.0,3/17,7.41%,GPR39;APP;CCL23
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.1786833855799373,-0.7684362027567516,0.7384615384615385,1.0,1.0,19/19,82.47%,APP;CCL23;PTK2B;RAP1A;SCIMP;DUSP4;TEK;CD44;TIMP3;SLC30A10;CCL14;APOE;FN1;CX3CL1;CD4;SYK;PTPN2;DLG1;NOD2
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.18153364632237873,0.7680443261672543,0.7121212121212122,0.9772948104255368,1.0,17/17,82.08%,PIK3CD;TNFRSF21;SYK;CD4;NFAM1;THY1;PSMB9;BCAR1;NFATC2;MNDA;GRAP2;ZAP70;SH2B2;PTPRJ;PIK3CB;PAK2;TEC
prerank,Elsevier_Pathway_Collection__Proteins Involved in Diabetic Nephropathy,0.1818466353677622,0.764496517350653,0.7777777777777778,0.9777314393040097,1.0,16/17,73.20%,PTK2;CREB1;PPARA;HGF;FN1;APOE;SERPINE1;CYBA;PTGS2;TIMP3;MMP2;VDR;SH2B2;BDKRB2;BMP4;ZEB1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.17276526162790698,0.7616456733835472,0.7837837837837838,0.9765370938975784,1.0,2/15,1.47%,PIK3CD;PTK2
prerank,MSigDB_Oncogenic_Signatures__RB P107 DN.V1 UP,0.18928052325581396,0.761129018908343,0.765625,0.9719003354579769,1.0,4/15,18.38%,CDC45;FANCL;HAUS8;CDH2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Melanoma,0.143617176766348,0.7604394873309763,0.7459016393442623,0.9675936969114107,1.0,14/28,37.76%,PTK2;CREB1;PLAUR;CDK6;CDH2;SYK;ERBB3;IGF2BP3;IGFBP3;CDH1;MELTF;HGF;FN1;LGALS3
prerank,KEGG_2021_Human__Human cytomegalovirus infection,-0.16175105334571166,-0.757931295200418,0.8032786885245902,1.0,1.0,6/22,20.39%,AKT3;CREB3L2;PTK2B;MAP2K6;PIK3CB;RB1
prerank,MSigDB_Oncogenic_Signatures__EGFR UP.V1 DN,0.1482580088447848,0.7540537371841717,0.7603305785123967,0.9719883859745897,1.0,14/25,41.62%,HIRA;TRIM24;FANCL;GTF2I;SLC27A2;BRIP1;ELOVL2;DEPDC1;PRR7;CTSH;CPE;CYBA;DLC1;COL9A3
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,0.13582937136819853,0.753643781348737,0.8067226890756303,0.9615848377184919,1.0,32/33,82.63%,PTK2;ARHGEF7;ACTR3;CREB1;DLG1;UPF2;CNTNAP1;ARHGAP39;SPTBN2;PSMB9;COL9A2;COL4A5;GPRIN1;DPYSL3;MAPK13;COL9A3;DPYSL2;ITGA2;MMP2;SLIT3;ABLIM3;SEMA4D;DSCAML1;COL4A4;GRB10;EFNB2;ITGA1;ADAM10;GRIN2B;PIK3CB;NTN4;LDB2
prerank,Reactome_2022__Axon Guidance R-HSA-422475,0.13582937136819853,0.753643781348737,0.8067226890756303,0.9615848377184919,1.0,32/33,82.63%,PTK2;ARHGEF7;ACTR3;CREB1;DLG1;UPF2;CNTNAP1;ARHGAP39;SPTBN2;PSMB9;COL9A2;COL4A5;GPRIN1;DPYSL3;MAPK13;COL9A3;DPYSL2;ITGA2;MMP2;SLIT3;ABLIM3;SEMA4D;DSCAML1;COL4A4;GRB10;EFNB2;ITGA1;ADAM10;GRIN2B;PIK3CB;NTN4;LDB2
prerank,Reactome_2022__Metabolism R-HSA-1430728,-0.08960112293835544,-0.7524543503300203,0.8525641025641025,1.0,1.0,45/162,27.34%,PLAAT3;CYP2C8;SBF2;GGT5;STS;DPYS;ZDHHC21;NCOA1;ALDOB;AHRR;CYP4V2;DMGDH;SGPP1;AGK;SULT1B1;TPST1;TTPA;SUCLG2;DERA;PLEKHA5;SLCO1A2;SLC36A4;ABHD3;AADAC;CREBBP;GSTA1;GSTA2;CDK19;PDSS2;COX16;PIK3CB;HACD2;VNN1;HIBADH;PHKB;CYP39A1;LIN9;GLYAT;RAP1A;NDUFS4;PLPP1;NDUFAF2;ACSM2B;SGPL1;PARP8
prerank,WikiPathway_2021_Human__VEGFA-VEGFR2 Signaling Pathway WP3888,-0.13024498704689633,-0.747309202331632,0.78125,1.0,1.0,11/38,24.79%,CYP2C8;RAP1B;CREBBP;SOD2;LDB2;PTK2B;MAP2K6;PAK2;ADAM10;PTPRJ;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.15860962566844922,0.7466596712137478,0.8305084745762712,0.9675379615971738,1.0,8/20,28.26%,RBL1;DIS3L2;WWP2;ERN1;PRKAA2;IGF2BP1;MYCN;IGF2BP3
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.1750782472613458,0.7420447022987783,0.7966101694915254,0.9691409969661404,1.0,11/17,45.25%,PRPF40A;ABI2;SIPA1L3;CNTNAP1;THY1;APOE;SYNE3;FMNL2;MICAL3;DPYSL2;PACSIN3
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.17191093386507142,-0.7418593739024797,0.75,1.0,1.0,13/20,47.57%,PROS1;TNFRSF10B;PIK3CB;SLC7A9;GLG1;ITGAX;SLC7A8;TEK;PROCR;CD44;FCAMR;SDC3;CD2
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,0.1687745520743508,0.7378093986991257,0.7983193277310925,0.970270818190238,1.0,12/17,50.73%,ARHGEF7;RAB7A;DEPDC1B;FNBP1;ARHGAP39;FMNL2;DLC1;SPATA13;IQGAP3;CDC42EP1;DOCK11;ARHGAP4
prerank,MSigDB_Oncogenic_Signatures__LTE2 UP.V1 DN,0.15306122448979587,0.7357419856319889,0.8153846153846154,0.9679241191963472,1.0,21/21,84.94%,GTF2I;SP110;SVIL;ARHGAP12;PSMB9;ELOVL2;FHL2;DLC1;COL9A3;AMMECR1;IFI6;KLF4;PRSS23;HERC5;HERC6;OASL;GRB10;ALG13;IFI44L;OAS1;DNAJB14
prerank,TRRUST_Transcription_Factors_2019__SP1 mouse,-0.16617361292380872,-0.7286088251472082,0.7874015748031497,1.0,1.0,7/18,29.88%,APP;SOD2;TEC;SP4;LIPE;CCND2;BMP4
prerank,Elsevier_Pathway_Collection__Prostate Cancer,0.17656250000000004,0.7236821559025327,0.8103448275862069,0.9801523065065888,1.0,15/15,82.55%,PTK2;CASP7;IGFBP3;HGF;FN1;GLS;PTGS2;PRLR;MMP2;TMPRSS2;VDR;STAT5A;TGFB1I1;RB1;PTK2B
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.18110650510204088,-0.7228617552895784,0.784,1.0,1.0,6/15,29.03%,GGT5;ABCD3;AASDH;ACSM2B;SGPL1;ECHDC3
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.1282483693148895,-0.7208719970608994,0.8231292517006803,1.0,1.0,14/37,32.28%,NR2C2;MBD5;BTD;WDPCP;ATXN10;LDB2;WWP1;SHH;FEZ1;PMP22;DCHS1;NRG1;ADGRA2;PCDH1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.16178253119429586,-0.7184441927277938,0.7841726618705036,1.0,1.0,19/20,76.91%,TPST1;TTPA;PROS1;VNN1;SLC22A1;CYP1A2;HRG;ITIH1;CDO1;HPRT1;RBP4;BCAR1;SERPINE1;PYCR1;MAN1A1;APOE;CYP2S1;MAOA;PTGR1
prerank,MSigDB_Oncogenic_Signatures__PTEN DN.V1 DN,0.17149947309378932,0.7165523207776684,0.7967479674796748,0.984867529806636,1.0,13/16,57.07%,LIN7A;ETV5;KCNJ10;PROX1;KRT23;PSMB9;SGCE;PAH;TBX3;FOSL1;CDO1;ALX3;SEMA4D
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.17224178403755872,-0.7149869730284611,0.8028169014084507,1.0,1.0,10/17,43.47%,PLAAT3;DEPTOR;MREG;AMFR;INHBB;IL17RB;PRSS23;KLF4;AQP3;CD44
prerank,TRRUST_Transcription_Factors_2019__JUN human,0.16910289968385628,0.7045393146805377,0.8467741935483871,0.9959806297428371,1.0,5/16,24.48%,SLC19A1;TNFRSF10A;PLAUR;PPARA;SYK
prerank,KEGG_2021_Human__MicroRNAs in cancer,0.16497263487099295,0.7021694075199125,0.8478260869565217,0.9936504682230527,1.0,16/16,83.71%,PIK3CD;CDK6;NOTCH3;IGF2BP1;ERBB3;KIF23;GLS;SLC7A1;PTGS2;TIMP3;CD44;CYP1B1;CCND2;ZEB1;PIK3CB;CREBBP
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,-0.14378703973574275,-0.6974566652558409,0.7950819672131147,1.0,1.0,25/26,80.54%,MUC6;ALDOB;ADAMTS5;ADAMTS2;ALG6;ALG13;ADAMTS9;ADAMTSL5;CYP4F22;GALNT3;CYP1B1;GYG2;ADAMTSL2;SDC3;HPRT1;MOGAT2;CYP27B1;PAH;FDXR;SPON2;MAOA;AMN;G6PC1;NOTCH3;ACACA
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.114887400424488,0.6955663962314135,0.8778625954198473,0.9966617951700064,1.0,42/44,82.08%,PIK3CD;TNFRSF21;IRAK2;PTPN2;SYK;CD4;CX3CL1;MAOA;CD86;DPYSL3;MAPK13;HGF;FN1;IL1RN;STX1A;PTGS2;MNDA;CCL14;ANXA1;IL13RA1;SIGIRR;PRLR;GBP4;MMP2;IL12RB2;S1PR1;GRAP2;RORC;IL10RA;IL11RA;PTPN18;VAV1;IRAK3;GRB10;STAT5A;ITGAX;HCK;ZEB1;PTPRJ;PIK3CB;OAS1;TEC
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.15756127450980392,0.6927811393935193,0.8245614035087719,0.9949719159490366,1.0,7/20,26.56%,SENP1;PGPEP1L;RSPRY1;NLN;CASP7;TBL1X;F7
prerank,MSigDB_Oncogenic_Signatures__MTOR UP.V1 DN,0.1678403755868544,0.6917769996903944,0.8099173553719008,0.9911444761855551,1.0,14/17,58.53%,UBXN2A;UBR3;QPRT;MYCN;CHRD;CPE;STX1A;TNNC2;GDPD2;KCNC1;SLIT3;FBXO32;PRSS23;C1R
prerank,MSigDB_Oncogenic_Signatures__MEL18 DN.V1 UP,0.16390303998934502,0.6887428671360946,0.8220338983050848,0.9897056235379955,1.0,15/17,66.87%,SLC19A1;CHST11;PLAUR;ITGA3;ITGA4;SLC2A6;LRIG1;STX1A;FOSL1;ABLIM3;TEK;COL7A1;LTBP4;BDKRB2;CD83
prerank,MSigDB_Oncogenic_Signatures__ATF2 UP.V1 DN,-0.16289900397729204,-0.687293338501124,0.8559322033898306,1.0,1.0,13/16,57.99%,DENND4C;AADAC;SOD2;REV3L;PELI2;SLC12A8;CYP1B1;SDC3;SLIT3;BHMT;HKDC1;PTGS2;FRY
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,-0.15289057558507274,-0.6871761952044732,0.8703703703703703,1.0,1.0,9/20,33.36%,AKT3;CREB3L2;CREBBP;PIK3CB;RB1;CCND2;ADCY3;HLA-B;STAT5A
prerank,KEGG_2021_Human__Cellular senescence,-0.1586576051001383,-0.6863492189053597,0.7886178861788617,1.0,1.0,5/16,22.78%,AKT3;MAP2K6;PIK3CB;RB1;LIN9
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.17031250000000003,0.682405445505881,0.8189655172413793,0.9926237569981264,1.0,11/15,50.73%,SRGAP2B;THY1;CX3CL1;CHRD;CDH1;MCTP1;DPYSL3;SERPINE1;DLC1;STK26;ARHGAP4
prerank,Elsevier_Pathway_Collection__Proteins Involved in Glioma,0.12353079203907942,0.679976039662671,0.8596491228070176,0.9898787148171934,1.0,27/28,82.55%,PTK2;PLAUR;RFX1;NOTCH3;LRRC4;MYCN;ACSL5;HGF;FN1;LGALS3;FHL2;PTPRM;CYP27B1;UBE2C;PTGS2;MMP2;S1PR1;CD44;PAX8;VDR;CD9;DUSP4;NRG1;BMP4;SHH;RB1;PTK2B
prerank,WikiPathway_2021_Human__Ebola Virus Pathway on Host WP4217,-0.16519451530612256,-0.6797430224740996,0.9047619047619048,1.0,1.0,5/15,24.48%,RASA2;CREBBP;PIK3CB;NEDD4;ITGA1
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.14516450648055834,0.6743666113742823,0.8692307692307693,0.9922380190884974,1.0,9/20,33.13%,LCLAT1;PHTF2;TNFRSF21;IGF2R;CD48;CKAP4;LRRC8C;CD86;LRIG1
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,-0.13602564627801217,-0.6718149901772523,0.8442622950819673,1.0,1.0,4/27,7.41%,AKT3;GPR39;APP;CCL23
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.1539770625231225,-0.6717877868956466,0.8846153846153846,1.0,1.0,16/20,62.32%,RAP1B;PTK2B;RAP1A;CPEB3;RAPGEF3;TICAM2;AOC1;CD274;RORC;KCNE1;GFI1;TRPV1;SERPINE1;MPV17;AGAP3;GNG2
prerank,MSigDB_Oncogenic_Signatures__KRAS.600 UP.V1 DN,0.13339445583000753,0.6668657767449956,0.8715596330275229,0.9956479444339554,1.0,24/25,81.47%,FOXRED2;EPHX2;CD300A;SPTBN2;APOL3;CGREF1;CADM4;PTPRH;DENND1C;DLX6;PIK3C2B;KCNE1;PRRG4;NTF3;RTP4;NYNRIN;CIITA;APBB3;PDE11A;VILL;ADAMTS9;IFI44L;OAS1;MAP2K6
prerank,MSigDB_Oncogenic_Signatures__MEK UP.V1 DN,0.15432767545443601,0.6664000591442354,0.8861788617886179,0.9911389494089851,1.0,4/17,15.44%,HIRA;RALGAPA1;SP110;QPRT
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,-0.15378596364511854,-0.6589775349806298,0.8559322033898306,1.0,1.0,5/17,23.24%,AKT3;TNKS;PIK3CB;NEDD4;MTA3
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,-0.15378596364511854,-0.6589775349806298,0.8559322033898306,1.0,1.0,5/17,23.24%,AKT3;TNKS;PIK3CB;NEDD4;MTA3
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.1427450980392157,0.6539157531047034,0.9024390243902439,0.999839562017867,1.0,4/20,12.51%,PIK3CD;TRAF3;CREB1;CDK6
prerank,MSigDB_Oncogenic_Signatures__KRAS.600.LUNG.BREAST UP.V1 DN,-0.13474274619782117,-0.6474483709713348,0.8445945945945946,1.0,1.0,7/25,25.02%,TRIM58;DPYS;MYOM1;MAP2K6;GLYAT;PTPRJ;IFI44L
prerank,KEGG_2021_Human__Focal adhesion,0.13287625042149037,0.6394602877060684,0.9316239316239316,1.0,1.0,3/24,4.02%,PIK3CD;PTK2;PPP1R12A
prerank,MSigDB_Oncogenic_Signatures__ESC J1 UP LATE.V1 DN,0.14275430359937402,0.6361763161413266,0.9326923076923077,1.0,1.0,8/17,33.90%,SLC27A2;ZFP62;WWP2;SLC47A1;SALL1;ERCC6L;DAPP1;AMH
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.1187080960276837,-0.6345473492383211,0.9384615384615385,1.0,1.0,9/34,21.08%,AKT3;BIRC6;RAP1B;AGK;AP3B1;CREBBP;TNKS;PIK3CB;ADAM10
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,0.0946260446419126,0.6329852074544214,0.9369369369369369,1.0,1.0,19/62,27.64%,PTK2;ARHGEF7;PKP4;ACTR3;CREB1;TFDP2;DLG1;CDH2;UPF2;TBL1X;PPARA;CNTNAP1;ARHGAP39;PRDM14;SPTBN2;PKLR;KRT23;SALL1;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.11089949146503411,-0.6305532285310851,0.9398496240601504,1.0,1.0,16/40,33.90%,POU2F1;ZHX3;HMBOX1;ZBTB38;NR3C1;ZNF148;RB1;WWP1;MTA3;ZEB1;LBH;BMP4;NRG1;CIITA;PML;BASP1
prerank,TRRUST_Transcription_Factors_2019__RELA human,0.1193226662839923,0.6303614056303961,0.9193548387096774,1.0,1.0,27/28,83.17%,TNFRSF10A;PLAUR;CDK6;PPARA;PROX1;PSMB9;CD86;CDH1;AMH;FN1;IL1RN;SERPINE1;IL17C;CYP27B1;PTGS2;OPTN;MMP2;BHMT;COL7A1;TNFSF14;CD83;CCND2;ITGAX;LIPE;CYP3A7;TNFRSF10B;SOD2
prerank,TRRUST_Transcription_Factors_2019__NFKB1 human,0.11945795121150574,0.6288289386785809,0.9243697478991597,0.9995544566072796,1.0,28/29,83.17%,TNFRSF10A;PLAUR;NOD2;PROX1;PSMB9;CD86;CDH1;AMH;FN1;IL1RN;SERPINE1;IL17C;CYP27B1;PTGS2;A2M;OPTN;MMP2;BHMT;COL7A1;PGLYRP2;TNFSF14;CD83;CCND2;ITGAX;LIPE;CYP3A7;TNFRSF10B;SOD2
prerank,Reactome_2022__Immune System R-HSA-168256,0.07236621793583824,0.6267077457243649,0.9829059829059829,0.9964548329403882,1.0,48/161,29.88%,MTAP;PTK2;ERP44;UBE2H;ARHGEF7;TPP2;LMO7;ACTR3;TRAF3;CAB39;CREB1;ABI2;NUP210;PLAUR;LILRA2;HERC2;CD33;IGF2R;SLC27A2;IRAK2;RAB7A;RBBP6;CPPED1;MEFV;NOD2;CD300A;PTPN2;RNF130;CENPE;MANBA;ATAD3B;HERC4;CD53;SYK;MOSPD2;TNFRSF25;CD4;NFAM1;SPTBN2;PADI2;FBXO31;CKAP4;PSMB9;SIGLEC7;ITGA4;ITGAL;MAOA;EDA2R
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.14574218555054647,-0.621245481010356,0.9354838709677419,1.0,1.0,4/16,19.61%,AKT3;TEC;MAP2K6;PIK3CB
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.10605413105413111,0.6211218200351928,0.9767441860465116,0.9969693039206071,1.0,26/47,42.47%,PIK3CD;SRGAP2B;PTK2;YTHDF3;ELP3;ZNF304;TJP1;THY1;F7;CX3CL1;CAMSAP3;CHRD;SH3RF2;FGF1;CDH1;CARMIL2;MCTP1;DPYSL3;ULK4;SEMA3G;HGF;CTSH;SERPINE1;BCAR1;DLC1;SPATA13
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.146697965571205,0.618701576241938,0.928,0.9936512351026289,1.0,2/17,1.47%,PIK3CD;PTK2
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.10284892086330938,-0.6164937680087932,0.9333333333333333,1.0,1.0,18/45,33.90%,POU2F1;ZHX3;HMBOX1;ZBTB38;NR3C1;ZNF148;RB1;WWP1;MTA3;CPEB3;ZEB1;LBH;BMP4;NRG1;CIITA;PML;SLFN11;BASP1
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,-0.13860610806577917,-0.6140988116799206,0.9300699300699301,1.0,1.0,18/18,86.41%,NCOA1;SLCO1A2;CREBBP;CYP39A1;LIN9;ARV1;VDR;HSD17B3;SOAT2;CYP27B1;FDXR;PKMYT1;ELOVL6;PPARA;TBL1X;ACACA;HSD17B11;SLC27A2
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.14745359875805414,-0.610137212047489,0.8852459016393442,1.0,1.0,8/18,34.59%,NCS1;PTK2B;PAK2;SIPA1L1;RAP1A;RTN4RL1;KNDC1;EFNB2
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.12498029944838453,0.6092990580646646,0.8976377952755905,0.9962798626148229,1.0,9/26,27.64%,UBE2H;TPP2;LMO7;HERC2;RBBP6;RNF130;HERC4;FBXO31;PSMB9
prerank,MSigDB_Oncogenic_Signatures__E2F1 UP.V1 UP,0.143670916372804,0.6074992624162753,0.9495798319327731,0.992550048149165,1.0,9/16,40.93%,PKP4;TRAF3;CASP7;FNBP1;ARHGAP39;BOK;SLC7A1;CYBA;ZFPM1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.12163227056844078,0.6067117400907793,0.916030534351145,0.9883408385494344,1.0,12/26,36.68%,YTHDF3;LIN7A;RHOQ;CD2AP;ESPN;BAIAP2L2;CCDC40;ANKS4B;ACD;SHROOM1;DPYSL3;RSPH6A
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.14248711545613943,0.6056174640678206,0.9105691056910569,0.9844052630054801,1.0,10/19,36.83%,ASB3;LMO7;CDH2;FBXO31;CKAP4;PSMB9;IGFBP3;MELTF;FN1;APOE
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.13928012519561817,-0.596595008866959,0.8809523809523809,1.0,1.0,17/17,86.33%,GGT5;APP;ADAM10;CIITA;PML;IRAK3;PTPN18;CD274;SMPD1;TIMP3;SIGIRR;ANXA1;CYP27B1;DPYSL3;PTPN2;MEFV;IRAK2
prerank,MSigDB_Oncogenic_Signatures__PRC2 EDD UP.V1 UP,0.13557188541879295,0.5917309418518051,0.9609375,0.9898355688971587,1.0,2/17,3.94%,CDC45;LIN7A
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.1280432136335971,-0.5887555401042992,0.9310344827586207,1.0,1.0,21/23,74.67%,GGT5;CCL23;TPST1;VNN1;CIITA;BDKRB2;ADGRE5;C5AR2;CD44;CDO1;ANXA1;NAIP;CCL14;CYBA;HDAC9;LY75;IL1RN;ITGAL;CX3CL1;APOL3;NFAM1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.13714733542319746,-0.5881965224353789,0.9694656488549618,1.0,1.0,12/19,46.95%,TRIM58;APP;PTK2B;OAS1;VNN1;HCK;CIITA;PML;PGLYRP2;ZAP70;SMPD1;IFI6
prerank,MSigDB_Oncogenic_Signatures__RAF UP.V1 UP,0.12437106918238997,0.5879350012059236,0.9586776859504132,0.9881704782362488,1.0,14/23,47.80%,LRP5;TNFRSF21;ETV5;HSD17B11;NDC80;PSMB9;SLC2A6;FGF1;MAN1A1;SGCE;COTL1;RNF144A;FCHSD2;OPTN
prerank,MSigDB_Oncogenic_Signatures__PRC1 BMI UP.V1 UP,0.12882492870968218,0.5874057164384201,0.9473684210526315,0.9839009282726815,1.0,4/18,17.37%,EPHX2;MTHFS;QPRT;SLC25A23
prerank,KEGG_2021_Human__Pathways in cancer,0.09169185275379967,0.5872966506279581,0.952,0.9793971431329104,1.0,5/52,4.56%,PIK3CD;LPAR1;PTK2;LRP5;MSH2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Arterial Hypertension,-0.12235563178959405,-0.5845853672889352,0.9618320610687023,1.0,1.0,19/23,63.94%,PDE5A;NR3C1;SOD2;PTK2B;NEDD4;SHH;BMP4;BDKRB2;VDR;SLC4A5;CYP1B1;TIMP3;TRPV1;PTGS2;SLC6A4;SERPINE1;APOE;FN1;HGF
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,-0.12772977219167328,-0.5831750899850475,0.9242424242424242,1.0,1.0,3/22,7.41%,GPR39;APP;CCL23
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.13515709642470203,-0.5783395130163047,0.9586776859504132,1.0,1.0,10/17,42.55%,GGT5;GPR39;RB1;HCK;ADCY3;HRH2;CD163;KLF4;TEK;FNDC4
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.14204545454545456,-0.5761921040434377,0.9453125,1.0,1.0,6/15,31.43%,ERC1;GRIN2B;GRIK5;PMP22;SNPH;HRH2
prerank,MSigDB_Oncogenic_Signatures__PRC2 SUZ12 UP.V1 UP,0.13502902866268526,0.5728463554967227,0.9495798319327731,0.9827225638749564,1.0,2/16,3.63%,ST3GAL1;EPHX2
prerank,MSigDB_Oncogenic_Signatures__GCNP SHH UP EARLY.V1 UP,-0.1289617486338797,-0.5714829610477452,0.9384615384615385,1.0,1.0,4/20,13.51%,CYP2C8;PDS5B;ATL2;SLC23A2
prerank,Elsevier_Pathway_Collection__Proteins Involved in Amyotrophic Lateral Sclerosis,-0.143098714475335,-0.5713362179058156,0.9548872180451128,1.0,1.0,15/16,76.68%,APP;CREBBP;RB1;NRG1;NTF3;CD44;MAOB;OPTN;TIMP3;PTGS2;LGALS3;APOE;HGF;FGF1;SORT1
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,-0.09579339723109688,-0.5661184359958598,0.991869918699187,1.0,1.0,28/43,54.21%,POU2F1;APP;RAP1B;GSTA2;PTK2B;TEC;MAP2K6;PIK3CB;ZEB1;HCK;ITGAX;IL21R;STAT5A;PELI2;DUSP4;IRAK3;VAV1;IL17RB;PTPN18;IL11RA;IL10RA;RORC;S1PR1;IL12RB2;MMP2;SIGIRR;IL13RA1;ANXA1
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,-0.11758748164278121,-0.5476628718531122,0.9621212121212122,1.0,1.0,20/21,82.08%,RAP1B;RASA2;PIK3CB;GRIN2B;RAP1A;NRG1;DUSP4;PDE6D;TEK;RASGRP3;ZDHHC9;KLB;FN1;GPRIN1;FGF1;PSMB9;ERBB3;SPTBN2;KSR1;DLG1
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,-0.11758748164278121,-0.5476628718531122,0.9621212121212122,1.0,1.0,20/21,82.08%,RAP1B;RASA2;PIK3CB;GRIN2B;RAP1A;NRG1;DUSP4;PDE6D;TEK;RASGRP3;ZDHHC9;KLB;FN1;GPRIN1;FGF1;PSMB9;ERBB3;SPTBN2;KSR1;DLG1
prerank,MSigDB_Oncogenic_Signatures__IL2 UP.V1 UP,-0.1292467948717949,-0.5436145983362296,0.9761904761904762,1.0,1.0,13/15,66.87%,NCS1;CDCP1;INHBB;DUSP4;TNFSF14;VDR;FOSL1;RNF144A;FOSL2;LGALSL;HK2;RSPH6A;PRR7
prerank,MSigDB_Oncogenic_Signatures__PRC2 EZH2 UP.V1 DN,-0.12759397024275648,-0.52425561307614,0.9849624060150376,1.0,1.0,13/18,56.29%,CDCP1;DCBLD2;PIK3CB;FXYD6;MTHFD2L;CLEC2B;KLF4;PIR;ABLIM3;AMMECR1;TUB;ITGA2;PPFIA4
prerank,Elsevier_Pathway_Collection__Proteins Involved in Myocardial Ischemia,0.11567693854616432,0.512101603194436,0.991304347826087,1.0,1.0,2/19,3.63%,PTK2;EPHX2
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.07641402313533449,0.5067735969799972,0.9910714285714286,1.0,1.0,61/63,88.42%,MELK;PTK2;PRMT2;TNFRSF10A;TRIM24;ARHGEF7;PLAUR;TJP1;ING5;AATF;PRKAA2;NIBAN2;PLEKHG5;TNFRSF25;IGFBP3;CX3CL1;ARHGEF18;SH3RF2;PRR7;HGF;CTSH;BOK;FHL2;SH3RF1;BCAR1;TNFRSF10D;TBX3;MNDA;NAIP;ANXA1;PRAP1;FLNA;STK26;PRLR;DAPK2;IFI6;SMPD1;CD44;SEMA4D;CYP1B1;TEK;CSRNP3;PAX8;CD27;NTF3;VAV1;HRG;BMP4;CCND2;HCK;SHH;ANKRD13C;ADAM10;PAK2;TNFRSF10B;PTK2B;CREBBP;ARHGEF26;WNK3;ERC1;TOMM70
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,-0.0910430839002268,-0.49673875727612815,0.9851851851851852,1.0,1.0,4/35,7.41%,AKT3;GPR39;APP;CCL23
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.08451467055997734,-0.49311676344181293,0.9847328244274809,1.0,1.0,14/46,29.88%,BIRC6;ARHGAP10;ERC1;WNK3;SOD2;PTK2B;PAK2;RB1;ADAM10;MAP2K5;SHH;HCK;CCND2;BMP4
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.10907369844489519,-0.4912414092917306,1.0,1.0,1.0,19/20,82.47%,APP;CCL23;PTK2B;PTPRJ;RAP1A;SCIMP;PELI2;TEK;CD44;PIK3R6;MID1;SLC30A10;CCL14;APOE;FGF1;CX3CL1;CD4;KSR1;NOD2
prerank,KEGG_2021_Human__Pathways of neurodegeneration,-0.11226596426283197,-0.472370506846615,1.0,1.0,1.0,5/18,25.25%,DNAH14;APP;MAP2K6;GRIN2B;NDUFS4
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,0.08782864102013038,0.4705474634149575,1.0,1.0,1.0,8/26,27.64%,PTK2;ARHGEF7;DLG1;KSR1;IGF2BP1;SPTBN2;ERBB3;PSMB9
prerank,TRRUST_Transcription_Factors_2019__SP1 human,0.07662441475391116,0.46376779190385026,0.9915966386554622,1.0,1.0,41/44,83.17%,SLC19A1;LRP5;CREB1;PLAUR;CDK6;CD2AP;HSD17B11;CDH2;CBS;F7;MYCN;IGFBP3;HGF;APOE;SERPINE1;DPYSL2;PTGS2;MNDA;ITGA2;SIGIRR;TIMP3;MAOB;MMP2;SMPD1;CD44;CYP1B1;CD163;VDR;COL7A1;LTBP4;PGLYRP2;ADGRE5;TNFSF14;CD83;CCND2;ITGAX;SGPL1;ADAM10;CYP3A7;TNFRSF10B;SOD2
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.08309694012632844,-0.44333272562291876,1.0,1.0,1.0,11/36,29.88%,BIRC6;ARHGAP10;ERC1;WNK3;PTK2B;PAK2;ADAM10;SHH;HCK;CCND2;BMP4
prerank,MSigDB_Oncogenic_Signatures__RAF UP.V1 DN,-0.10784970238095244,-0.4388230684741586,0.9924242424242424,0.9959268445143468,1.0,6/15,34.59%,TFPI;KDM6A;THADA;PMP22;GALC;EFNB2
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.05996144386093195,0.4267096456064059,1.0,1.0,1.0,22/67,31.81%,THAP12;DLG3;PTK2;LRP5;DIS3L2;TJP1;CD33;CDK6;ING5;PTPN2;KSR1;NIBAN2;PROX1;CGREF1;ERBB3;CADM4;IGFBP3;CX3CL1;SAPCD2;AXIN2;CD86;FGF1
prerank,MSigDB_Hallmark_2020__Apoptosis,0.0826865957650665,0.35456988950300883,1.0,0.9997564054299444,1.0,16/17,83.71%,PTK2;IGF2R;CASP7;ERBB3;HGF;LGALS3;FDXR;ANXA1;TIMP3;MMP2;CD2;CD44;CCND2;FEZ1;SOD2;CREBBP
